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ABSTRACT 
A Stereospecific Pd-Catalyzed Suzuki Cross-Coupling Reaction and a Statistical 




Advisor: Prof. Mark R. Biscoe 
The development of palladium-catalyzed carbon-carbon cross-coupling reactions has 
profoundly influenced the manner through which we approach the synthesis of complex organic 
molecules. Among established cross-coupling reactions, which include Kumada, Negishi, and Stille 
reactions, the Suzuki cross-coupling reaction exhibits particularly wide functional group 
compatibility, while employing non-toxic, air-stable organoboron nucleophiles. Conventional 
studies of Pd-catalyzed Suzuki cross-coupling reactions have focused on C(sp2)-C(sp2) cross-
coupling reactions, which result in the formation of planar products. Conceptually, the use of C(sp3) 
(secondary) nucleophiles would enable the reliable manipulation of organic molecules in three 
dimensions. However, this process has not been achievable due to the slow rate of transmetallation 
of secondary alkylboron nucleophiles, and the subsequent isomerization of alkyl units following 
transmetallation to palladium. Herein, we describe the development of a general process for Pd-
catalyzed cross-coupling reactions involving alkylboron nucleophiles using racemic and 
enantioenriched alkylboron nucleophiles. The origin of stereoselectivity was investigated through 
correlation of parameterized phosphine properties to stereochemical outcomes. A stereodivergent 
cross-coupling reaction was developed in which stereoretention and stereoinversion could be 
 v 
selectively achieved through the proper choice of ligand. A broad range of aryl chloride or bromide 
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1.1 Origin of transition metal catalyzed C-C bond forming cross-coupling reaction 
Transition metal catalyzed cross-coupling reactions provide an alternative route to carbon-
carbon construction. The long history of the development of this topic could be traced back to a 
century ago, when first type of carbon-carbon homo-coupling was reported.[1]  
 
Figure 1-1. General Scheme for Transition Metal(Pd) Catalyzed Cross-Coupling Reaction 
 
In modern cross-coupling chemistry, a main group organometallic nucleophile and aryl 
electrophile are coupled using a transition metal catalyst. Li, Mg, Zn, Sn, and B most commonly 
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and pseudohalides most commonly constitute the electrophilic component. Palladium and nickel 
most commonly constitute the transition metals used as catalysts. The catalytic cycle of metal-
catalyzed cross-coupling reaction generally proceeds via three elementary steps: oxidative addition, 
transmetallation and reductive elimination (Figure 1-1). Because of the high covalency of C–B 
bonds, organoboron compounds tend to be significantly less nucleophilic than organolithium, 
organomagnesium, organozinc, and organotin compounds, which contain more ionic C–M bonds. 
However, less nucleophilic organoboron nucleophiles also tend to be highly stable, which makes 
Suzuki reactions more mild, selective, and broadly applicable than other cross-coupling reactions. 
Additionally, the boron element is known to exhibit low toxicity and to be environmentally friendly, 
which motivates its large-scale industrial use. The Suzuki reaction is the most adopted named metal 
catalyzed cross-coupling reaction in both publications and patents. And for the significant 
contribution and profound affect to both of industry and academia, Suzuki was awarded with Noble 












1.2 Development of C-C bond formation via Suzuki cross-coupling reaction 
1.2.1 Palladium/ Nickel-Catalyzed C(sp2)-C(sp2) Formation (earlier stage) 
 
 
Figure 1-2. Palladium- and Nickel-Catalyzed C(sp2)-C(sp2) Cross-Coupling Reactions 
 
The earliest Suzuki C-C bond cross-coupling reactions were C(sp2)-C(sp2) bond-forming 
reactions between alkenyl catechol boronates (BCat) and vinyl halides (Figure 1-2a)[2,3] to generate 
conjugated dienes, and between alkenyl boronates and aryl halides (Figure 1-2b)[4] to form styrenyl 
products. Using conventional palladium-catalyzed Suzuki-Miyaura reaction of aryl bromides and 
iodides, C(sp2)-C(sp2) bonds could be readily generated between aryl/vinyl bromides or iodides and 
aryl/vinyl boronates or boronic acids in high efficiency.[5] Aryl chlorides, which are more desirable 
electrophiles due to their stability and availability, are more challenging to use due to slow 
oxidative addition.[6] As a result, only a few examples of electron-deficient N-heteroaryl chlorides 
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this problem, use of nickel catalysis in Suzuki cross-coupling reaction was investigated. The first 
nickel-catalyzed aryl-aryl cross-coupling reaction with aryl chloride was reported by Miyaura and 
coworkers (Figure 1-2c).[8] Ensuing research was focused on improving efficiency of catalysis.[9, 10] 
Over the years, the catalyst for this type of reaction was generalized by Percec, who employed 
NiCl2(dppe) with excess of ligand (dppe or PPh3) to achieve the coupling of aryl halides and aryl 



















1.2.2 C(sp2)-C(sp3) Cross-Coupling Reaction 
 
Figure 1-3. Palladium- or Nickel-Catalyzed C(sp2)-C(sp3) Cross-Coupling Reactions 
 
Transition-metal-catalyzed cross-coupling reactions involving alkyl moieties also represent an 
important class of coupling reactions. However, use of an alkyl species is considerably more 
challenging than corresponding aryl and vinyl analogues due to slow transmetallation to the 
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hydrodehalogenation.[5, 6a] The first nickel-catalyzed Suzuki cross-coupling reaction between an 
alkyl halide and arylboron species was reported by Fu and Zhou. Using Ni(cod)2 and bidentate 
nitrogen ligand (bathophenanthroline), cyclic, acyclic and primary alkyl iodides and bromides were 
shown to undergo cross-coupling reactions with a broad range of aryl and alkenyl boronic acids 
(Figure 1-3ab).[12]  Progress using palladium has occurred more slowly, though investigations 
started earlier. Because nickel catalysts can undergo oxidative addition via a radical mechanism,[6, 19, 
20] secondary alkyl electrophiles are viable substrates for use in cross-coupling reactions. However, 
palladium catalysts typically undergo oxidative addition via a direct (SN2-type) substitution 
reaction,[5] precludes the use of palladium in most cases. Therefore, Pd-catalyzed C(sp2)-C(sp3) 
reactions have been mainly pursued using C(sp3) nucleophiles. The first successful example of this 
type of reaction was described by Suzuki and coworkers (Figure 1-3c).[13] Other than boronic acids 
or boronates, used for alkenyl/aryl analogues, alkyl 9-BBN was employed to introduce C(sp3) 
nucleophiles. But this application is only limited to primary alkyl 9-BBN, and the reactions with 
secondary alkyl boron nucleophiles are very slow.[13a] A couple of years later, the first example of 
coupling with secondary boron nucleophiles, cyclopentylboronic acid, was demonstrated by Fu, 
although most other cases in that work involved C(sp2)-C(sp2) coupling (Figure 1-3d).[14] Two 
years later, Hartwig and coworkers demonstrated the coupling reaction of sec-butyl boronic acid 
with aryl bromide using a palladium catalyst supported by a ferrocenyl ligand, though this work 
also focused mainly on C(sp2)-C(sp2) examples (Figure 1-3e).[15] The first dedicated efforts to 
employ secondary alkylboron nucleophiles in Pd-catalyzed cross-coupling reaction were 
independently made in 2008 by Molander and van den Hoogenband.  In this work, not only cyclic 
alkyl nucleophiles, but also acyclic nucleophiles were employed. (Figure 1-3f).[16]  These studies 
also made use of potassium alkyltrifluoroborates, which constitute a stable and storable alkyl boron 
 7 
source.[17] For cross-coupling reactions using potassium isopropyl trilfuoroborate, significant 
formation of linear by-products were observed, which was proposed to generate from β-H 
elimination/ re-insertion after transmetallation and reductive elimination. This limitation has 
remained the primary obstacle and challenge to the use of alkylboron nucleophiles in Suzuki 
couplings. 
 
1.2.3 Development asymmetric or stereospecific cross-coupling reaction 
The three-dimensional structure of natural products and bioactive chemicals can have a 
profound influence on their pharmacologic properties. One enantiomer of a molecular could elicit a 
desired therapeutic response, while the other enantiomer produces a harmful effect. The ability to 
achieve stereocontrol in cross-coupling reactions using secondary alkyl moieties enables the 
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Asymmetric catalysis enables the predominant formation of one enantiomer in reactions that 
form stereogenic centers.[18] Fu and Saito reported an early successful protocol for the asymmetric 
formation of C–C bonds through a stereoconvergent, Ni-catalyzed Suzuki reaction (Figure 1-4).[19] 
Since the oxidative addition of alkyl halide in nickel chemistry involves a radical process,[12] chiral 
ligands were employed to bias the stereochemistry of the C–Ni bond,  and enable the preferential 




X + Ar 9-BBN
NiBr2 • diglyme (8 mol %)


























NiBr2 • diglyme (10 mol %)











NiBr2 • diglyme (10 mol %)
Ligand 4 (12 mol %)
KOtBu (1.2 equiv)
n-hexanol (2.0 equiv)












NiBr2 • diglyme (10 mol %)












Figure 1-5. Nickel Catalyzed Stereoconvergent Cross-Coupling Reactions with Chiral Ligands by 
Fu 
 
In the following several years from the first discovery,[19] Fu and coworkers conducted 
comprehensive studies of stereoconvergent Ni-catalyzed Suzuki reactions and established several 
sets of specified conditions for various types of alkyl halides electrophiles (Figure 1-5).[20] 
Although this methodology provided an accessible route to create chiral center, it was difficult to 
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results between different electrophiles. Therefore, it was often necessary to re-engineer chiral 
ligands and re-optimize the condition according to the substrates.[21]  
An alternative approach that would circumvent this concern involves the use of 
enantioenriched main group alkyl organometallic nucleophiles in stereospecific cross-coupling 
reactions that would preserve the initial stereochemistry. One challenge of this work is the selection 
of proper configurationally stable organometallic nucleophiles for use in cross-coupling reaction.  
There exists an inverse relationship between “nucleophilicity” and “configurational stability”.  
Therefore, main group organemetallic nucleophiles that tend to be configurational stable also tend 
to exhibit low nucleophilicity. Additionally, the steric bulk of secondary and tertiary alkyl 
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Figure 1-6. Palladium Catalyzed Stereospecific Stille Cross-Coupling Reaction with 
Enantioenriched Alkyl Stannene Nucleophiles 
 
One approach to stereospecific cross-coupling reactions involves the use optically active 
alkyltin reagents in stereospecific palladium-catalyzed reactions. Figure 1-6 shows the successful 
examples of stereospecific Stille cross-coupling reaction using enantioenriched organotin 
nucleophiles.[23]  However, compared to alkylstannane nucleophiles, alkylboron nucleophiles 
generally are more stable and contain only one alkyl unit. Therefore, the potential formation of 
byproducts from competitive transmetallation processes is not a major concern in Suzuki coupling 
with alkylboron nucleophiles. However, the increased covalency of the carbon-boron bond 
coincides with the reduction of nucleophilicity.[21] Additionally, a major issue in coupling with 
secondary alkylboron nucleophiles, revealed by previous research, is the isomerization from β-H 
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elimination, alkylboron nucleophiles bearing activating group have typically been employed in 
stereospecific Pd-catalyzed Suzuki cross-coupling reaction.  
  
 
Figure 1-7. Stereospecific Cross-Coupling Reaction of Enantioenriched Benzylboronic Esters and 
Alkyl Iodides by Crudden 
 
The first Pd-catalyzed stereospecific Suzuki cross-coupling reaction was reported by Crudden 
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organoboronates (Figure 1-7a).[24a] In these reactions, palladium(0) (Pd(dba)2) with excess PPh3 
was used as the catalyst, and stoichiometric Ag2O was employed to promote dehalogenation and 
formation of cationic Pd(II) intermediate, which was proposed to facilitate the transmetallation of 
enantioenriched benzylic boronate esters (BPin). The scope of this reaction was limited to only aryl 
iodides, and no heteroaromatic electrophiles were employed. A few years later, the same group 
demonstrated another stereoretentive cross-coupling reaction with dibenzylic nucleophiles (Bneop) 
with a modified conditions, which provided an accessible way to prepare enantioenriched 
triarylmethanes (Figure 1-7b).[24b]  
 
Figure 1-8. Stereospecific Cross-Coupling Reaction of Enantioenriched Alkyl β-
Trifluoroboratoamides and Aryl Chlorides by Molander 
 
In 2010, Molander and coworkers applied enantioenriched alkyltrifluoborates to stereospecific 
Suzuki cross-coupling reaction (Figure 1-8).[25]  They reported a highly stereospecific cross-
coupling reaction between secondary alkyl β-trifluoroboratoamides and aryl electrophiles with 
stereoinvertion, which was proposed to be directed by the intramolecular coordination of β-carbonyl 
to boron.  
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Figure 1-9. Stereospecific Cross-Coupling Reactions of Enantioenriched α-
(Acylamino)benzylboronic Esters and Aryl Electrophiles by Suginome and Ohumura 
  
Suginome and Ohmura also investigated the effect of intramolecular coordination on 
stereospecificity.[26] In their first investigation, they showed that coupling between α-
(acylamino)benzylboronate (Bpin) nucleophiles and aryl electrophiles using XPhos occurred with 
inversion of configuration. (Figure 1-9a).[26a] Following this, they investigated the effects of protic 
and lewis acid additives on the stereospecificity of the reactions (Figure 1-9b).[26b] They found in 
the use of a Zr(IV) Lewis acid in iPrOH could result in a cross-coupling reactions that proceeded 
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Figure 1-10. Stereospecific Pd-catalyzed Cross-Coupling Reactions of Enantioenriched 1-
(Benzyloxy)alkyltrifluoroborates and Aryl Chlorides by Molander 
 
In 2012, Molander and coworkers reported a stereospecific Suzuzki cross-coupling reaction of 
enantioenriched 1-(benzyloxy)alkyltrifluoroborates and aryl halides, which occurred with retention 
of configuration. (Figure 1-10).[27] An intramolecular coordination was proposed, which could 
stabilize the intermediate of Pd complex after transmetallation, and prevent b-hydride elimination. 
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Figure 1-11. a) Stereospecific Pd-catalyzed Cross-Coupling Reactions of Enantioenriched 3,3-
diboronyl Carboxyesters and Aryl/vinyl Bromides by Hall; b) Stereoinvertive Transmetallation in 
the Pd-catalyzed Cross-Coupling Reaction of a Germinal diboronyl Reagent and an Aryl iodide by 
Morken 
 
Later on, Hall and coworkers reported a stereoinvertive cross-coupling reaction of an alkyl 
trifluoroborate, bearing a geminal 1,8-diaminoaphthalenyl(dan)boron unit. Under these conditions, 
the coupling selectively took place on carbon-BF3K over carbon-Bdan. This reaction was 
demonstrated with several electrophiles. Electro-deficient/rich aryl bromide, vinyl bromide and 
hetereoaromatic bromides could be all employed with high e.s. (Figure 1-11a).[28a] In 2014, an 
investigation in Morken’s group similarly reported an example of stereoinvertive cross-coupling 
reaction of secondary alkylboron geminal di-boronate (BPin) nucleophiles and 4-iodoanisole using 
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a mono-dentate chiral taddol-derived ligand palladium complex. The chirality was assigned via 
labelling one BPin as 10B, which was selectively coupling with aryl iodides (Figure 1-11b).[28b] 
Each of these methods provides access to enantioenriched benzylic boronate nucleophiles. 
1.3 Investigation on Mechanism of Suzuki Cross-Coupling Reaction 
 
Figure 1-12. 2 Proposed Catalytic Cycles for Palladium or Nickel Catalyzed Suzuki Cross-
Coupling Reaction 
 
To thoroughly investigate the process of Suzuki cross-coupling reaction, scientists have 
worked on mechanism over years. The Ni-catalyzed Suzuki cross-coupling reaction, using an alkyl 
halide, has been proposed to occur through a M(I)/M(II)/M(III) cycle (Figure 1-12b) via radical 
pathways.[6, 20] The Pd-catalyzed Suzuki cross-coupling reaction has been more extensively 
investigated than the Ni-catalyzed variant. A general catalytic cycle for the cross-coupling reaction 
catalyzed by palladium, containing oxidative addition-transmetallation-reductive elimination 






































catalyst  solvent base time, h yield% (viii/ix) 
Pd(PPh3)4 benzene none 6 0 
Pd(PPh3)4 benzene NaOEt(2) 2 99(100/0) 
Pd(PPh3)4 benzene NaOH(2) 2 99(100/0) 
Pd(PPh3)4 DMF Et3N(5) 20 54(10/90) 
PdCl2(PPh3)2 DMF Et3N(5) 20 66(8/92) 
Pd black DMF Et3N(5) 20 94(4/96) 
Pd black DMF NaOH(2) 6 86(56/44) 
Table 1-1. Reaction Conditions for Head-to-Head and Head-to-Tail Cross-Coupling 
 
Figure 1-13. “Heck” Addition-Elimination Mechanism for Head-to-Tail coupling 
 
Of the three major steps constituting the cycle, transmetallation has historically received the 
least attention.  Though C(sp2)-B compounds are intuitively unlikely to participate in the catalytic 
cycle of cross-coupling reaction because of their poor nucleophiliclity,[29] research showed a 
remarkable effect from base on the transmetallation to metal,[5, 30] which implied a proper selection 
of base and ligand is essential to transmetallation. With this knowledge, the earliest successful 
example of Suzuki cross-coupling reaction was carried out via coupling of (E)-1-hexenyl-1,3,2-
benzodioxaborole with aryl iodides. The ratio of two products (viii/ix) was related to selection of 
B + PhI
Pd-catalyst


























base (Table 1-1).[2] Normal “head to head” product (viii) was acquired via a typical Suzuki 
coupling process, when NaOEt or NaOH was used; yet, head to tail product (ix), was obtained 
primarily, when using Et3N. The process, obtaining head to tail product (ix) was later rationalized as 
a Heck-type addition-elimination process, (Figure 1-13).[31] 
 
Figure 1-14. Transmetallation via a Quaternized Borates 
 
As more research was conducted, it became evident that transmetallation between 
organopalladium(II) halides and organoboron compounds required quaternization of boron through 
formation of an “ate” complex, which amplified its nucleophilicity.[5] And the coupling between 
“ate” complexes with aryl halides, without additional base, has been observed (Figure 1-14a).[5, 32] 
The similar acceleration by quaternization of base anion was also observed in 
organotrifluoroborates (Figure 1-14b).[33]  
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Figure 1-16. Experiment Supporting Transmetallation via (Alkoxo)-Palladium Complexes 
 
An alternative proposed pathway involved transfer aryl/alkyl transfer from trivalent boron to 
the (alkoxo)-palladium(II) complexes (Figure 1-15). Although coupling of aryl halides require 
assistance of base, an observation of the coupling with allylic phenoxides under neutral condition 
suggested the possibility of transmetallation with (alkoxo)-palladium(II) (Figure 1-16a).[2b, 34] The 
reaction of isolated vinylpalladiumX complex with vinylboronate was dramatically effected by the 
identity of X (Cl or OMe), which provided another piece of evidence (Figure 1-16b).[2b] In other 
work by Alper, the coupling of (hydroxo)palladium complex with aryl boronic acid was 
demonstrated, which also supports this proposal (Figure 1-16c).[35] 
 
 
Figure 1-17. Palladium-Catalyzed Reactions of Propargyl Carbonates with Carbonucleophiles 
under Neutral Conditions 
a) RHC
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Figure 1-18. SE2 (coord) Transition State 
 
Additionally, research carried out by Suzuki and co-workers, showed an unexpected 
relationship between activity of carbon nucleophiles and its electron density, in which electron-
deficient aryl boronates were more active to transmetallation. This discovery suggested an SE2 
(coord) mechanism involving a coordination of the alkoxy ligand to the empty p-orbital of boron 
atom at transmetallation step (Figure 1-17).[36, 37] 
To investigate the two possible pathways of transmetallation via the SE2 (coord) mechanism, 
Hartwig performed a kinetic study of the “(alkoxo)palladium(II)” process. This study suggested a 
large preference for the “palladium(II) hydroxo” pathway (Figure 1-18).[38] In 2017, Denmark and 
coworkers provided the first structural evidence of a Pd-O-B linkage, via a low-temperature, rapid 









2. Palladium-catalyzed Suzuki cross-coupling reaction of secondary alkylboron nucleophiles 
and aryl chloride. 
2.1. Background 
 
Figure 2-1. Elaborated Catalytic Cycle of Suzuki Cross-Coupling Reaction of Aryl Halide with sec-
Alkylboron Nucleophile (i-PrB(OH)2) and Possible Side Reactions. 
 
Previously, Pd-catalyzed C(sp2)-C(sp3) Suzuki cross-coupling reactions have largely been 
applied to activated secondary nucleophiles, bearing benzylic,[24] α-benzoxy,[27] β-acetyl[25] or α-N-
Boc-amino[26] boron nucleophiles. Coupling reactions involving unactivated secondary boron 
nucleophiles had only been demonstrate with limited cases.[16] The primary challenge of using 
unactivated alkylboron nuclephiles, besides the slow transmetallation because of the low 
nuleophilicity and sterical bulk, is the generation of undesired rearranged by-products, which arise 
from competing β-H elimination/re-insertion pathways. In early work by Molander, it was shown 
that Pd(II) with tBu3P, nBuPAd2, or tBuPPh2 could be effective in C-C bond coupling with sec-
alkylboron nucleophiles. Among these three ligands, cross-coupling products formed using PtBu3 


























obtained.[16] Our goal is develop a general method that can be applied with unactivated secondary 
alkyl boron nucleophiles, which overcomes previous problems associated with isomerization and 
low yields. 
 
2.2. Optimization of Reaction Condition 
 
entry variations from above yield (%)a 2:3a 
1 none 98 >200:1 
2 2 mol % P(t-Bu)3 precatalyst 98 36:1 
3 2 mol % Pd(dba)2, 2 mol % P(t-Bu)3•HBF4  70 36:1 
4 Cs2CO3 (3 equiv) instead of K2CO3 <5 - 
5 K3PO4•H2O (3 equiv) instead of K2CO3 94 69:1 
6 5 mol % n-BuPAd2 precatalyst 89 4:1 
7 5 mol % PhP(t-Bu)2 precatalyst 94 32:1 
8 toluene/H2O 89 70:1 
9 THF instead of toluene <5 - 
10 dioxane instead of toluene <5 - 
11 methylcyclohexane instead of toluene 97 >200:1 
aYield and selectivities determined by GC 
Table 2-1. Optimization of Reaction Conditions for the Pd-Catalyzed Cross-Coupling of s-

















1 (5 mol %)
2 3
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As start of our research, the cross-coupling reaction of 4-chloroanisole and sec-butyl boronic 
acid was used as a model system (Table 2-1). Inspired by Molander’s previous work, we found 
isomerization could be suppressed using a preformed P(t-Bu)3 palladium precatalyst (1),[40] which 
could be activated in-situ to form a mono-ligated Pd(0) complex, and K2CO3 in a 2:1 mixture of 
toluene and water (entry 2). When Pd(dba)2 and P(t-Bu)3• HBF4 were used as the substitution 
palladium catalyst, the reaction did not reach completion (entry 3). When K2CO3 was replaced with 
Cs2CO3, the reaction completely failed (entry 5). Other than PtBu3, we also tried the precatalyst 
with other two ligands, used in Molander’s work (entry 6,7). Use of n-BuPAd2 and PhP(t-Bu)2 both 
resulted in varying amounts of rearrangement products. Other than toluene, methylcyclohexane 
could also be an alternative solvent with only a nominal change in the yield and selectivity of the 
resulting products (entry 11). However, the use of aprotic polar solvents THF and 1,4-dioxane 
resulted in no reaction (entry 9,10). By increasing the catalyst loading from 2 mol % to 5 mol %, 
enhanced selectivity for the branched product 2 was observed (entry 1). This set of conditions was 









2.3. Pd-Catalyzed Cross-Coupling Reactions of Secondary Alkylboronic Acids and Aryl Chloride 
 
Table 2-2. Pd-Catalyzed Cross-Coupling Reactions of Secondary Alkylboronic Acids and Aryl 
Chloride 
 
To evaluate the generality of the cross-coupling reaction, i-PrB(OH)2 (4) (no α-branching) and 
s-Bu(OH)2 (5) (with α-branching) were used as nucleophiles (Table 2-2). Both electron-rich and 
electron-deficient aryl chlorides provided the corresponding cross-coupling products in high yields 
(6/7a&b). Among these nucleophiles, presence of an ortho-substitutent was well tolerated in the 
reaction (6/7e). Additionally, heterocyclic aryl chlorides could work in these reactions as well with 
a decent yield (6/7d, f-h). For all substrates, an excellent ratio (>50:1) of retention to isomerization 
Ar Cl + R B(OH)2 Ar R
R = i-Pr (4)
R = s-Bu (5)
1.5 equiv.








































R = i-Pr (6)
















product was achieved. Nevertheless, for heteroaryl electrophiles with the chloride leaving group 
located directly on the heteroaryl ring (e.g. 3-chloropyrindine), the reaction uniformly gave poor 
results. From our observations, this constitutes the major scope limitation of the aryl chloride 
electrophiles. 
 
2.4. Pd-Catalyzed Cross-Coupling Reactions of Secondary Alkyltrifluoroborates and Aryl Chlorides 
 
Table 2-3. Pd-Catalyzed Cross-Coupling Reactions of Secondary Alkyltrifluoroborates and Aryl 
Chlorides 
Ar Cl + R BF3K Ar R
R = i-Pr (8)
R = s-Bu (9)
1.5 equiv.






































R = i-Pr (6’)


















Identical conditions to those used with secondary alkylboronic acid could be successfully 
employed with secondary alkyltrifluoroborates (8&9). Not surprisingly, a similar substrate scope 
was also achieved using secondary alkyltrifluoroborates (Table 2-3). For all substrates, high yields 
and ratios of retention to isomerization products were reproduced. Since secondary 
alkyltrifluoroborates are significantly more stable and accessible than their corresponding boronic 
acid analogues,[49] the ability to employ alkyltrifluoroborates reagents in this reaction greatly 





2.5. Investigation on Nucleophiles Scope 
 
Table 2-4. Pd-Catalyzed Cross-Coupling Reactions with Extensive Nucleophiles 
 











60 - 100 ºC














































Compared with secondary alkylboronic acid, the corresponding alkyltrifluoroborate showed 
its greater stability in the air, which allowed us to extend this method to more complicated 
nucleophilic coupling partner in forms of trifluoroborate (Table 2-4). With potassium 4-phenylbut-
2-yl trifluoroborates, the cross-coupling reaction worked comparably with active aryl chloride (10a-
c). For less active heteroaromatic chlorides, doubled catalyst loading (10 mol %), extended reaction 
time (48h), and a sealed Schlenk tube were required (10d,e). In these two cases, the reactions were 
conducted at a lower temperature to avoid protodeboronation. Not surprisingly, reactions involving 
symmetric, carbocyclic, secondary alkyltrifluoroborates provided cross-coupling products in high 
yield (10g-j). Although toluene was an effective solvent in all of these reactions, in some case, 




2.6. Research on Stereochemistry 
 
Figure 2-2. (a) Synthesis of (S)-13 from (S)-3-phenylbutyric acid (S)-11. (b) Suzuki Coupling of 
(R)-9 and PhCl. (c) Synthesis of (S)-14 from (S)-11. (d) Suzuki Coupling of (R)-12 and PhCl. 
 
To investigate the stereochemistry of this reaction, enantioenriched (R)-9 and (R)-12 were 
obtained from Brown’s[41] and Matteson’s[42] chiral auxiliary-based protocols. The assignments of 
stereocenter were further confirmed through oxidation[43] of (R)-9 and (R)-12 and comparison of the 
oxidized products with the corresponding commercially available, optically active alcohols. 
Derivatization of commercially available (S)-3-phenylbutyric acid (11) enabled access to (S)-13 and 
(S)-14 (Figure 2-2a and c), which provided reference for the coupling product. When (R)-9 was 
employed in a cross-coupling reaction with chlorobenzene, (S)-13 was obtained with inversion of 
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92 % ee (94 % es)
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comparison of the chiral GC trace of the isolated cross-coupling product to that of synthesized (S)-
13 (see chiral GC and HPLC in Supporting Information for more details). A similar stereochemical 
analysis was performed for the cross-coupling reaction of (R)-12 and chlorobenzene, which also 
showed stereoinversion in the formation of (S)-14 (Figure 2-2d). Both (S)-13 and (S)-14 were 
generated with high enatiospecificity (% es)[44] using this process. 
 
Figure 2-3. Use of (R)-9 and (R)-12 in Stereospecific Cross-Coupling Reactions with Aryl and 
Heteroaryl Chlorides. 
 
To further demonstrate the stereospecificity of the coupling, selected electrophiles from Tables 
2-3 and 2-4 were used with (R)-9 and (R)-12 (Figure 2-3). Because heterocyclic electrophiles play 
an important role in pharmaceutical industry and are typically one of the most difficult substrates to 
Ar Cl + R BF3K
Me H





60-100 ºC, 24-48 h
R=Me: 98% ee (R)-9
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(S)-10e
92% ee (94% es)
(S)-10d




use in metal-catalyzed processes, several hetrocyclic eletrophiles were used in this study ((S)-7d’,7f’ 
and (S)-10a,d,e). These reactions resulted in the formation of the corresponding (S)-cross-coupling 
products with little loss of enantiomeric excess. The high enantiospecificity (% es) of this process 
using heteroaromatic electrophiles should enable this process to be applied to the preparation of 
libraries of enantioenriched drug candidates. Thus, optically active alkylboron reagents such as (R)-
9 and (R)-12 could then be viewed as general building blocks for use in the rapid preparation of 
libraries of non-racemic molecules during the drug discovery process. 
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3. Investigation of Phosphine Ligand’s Effect on Stereospecificity of Suzuki Cross-Coupling 
Reaction using Enantioenriched Secondary Alkyltrifluoroborates 
3.1 Background  
In chapter 2, we described a Pd-PtBu3 catalyzed stereo-specific Suzuki cross-coupling reaction 
of aryl chlorides and enantioenriched secondary alkyl trifluoroborates. This process undergoes 
transmetallation via a stereoinvertive pathway.[45] In previous Suzuki reactions research, both 
inversion and retention of absolute configuration have been reported for different activated 
secondary alkylboron nucleophiles. Among those studies, Crudden[24] has demonstrated a 
stereoretentive Suzuki reactions by using benzylic alkylboron as nucleophiles, which is consistent 
with Molander’s[27] work in Suzuki reactions using α-OBn alkylboron as nucleophiles. On the other 
hand, a stereoinvertive process has been previously reported by Molander[25] and Suginome[26] for 
Suzuki reactions using activated secondary alkylboron nucleophiles containing β-coordinating 
groups. Additionally, the groups of Hall[28a] and Morken[28b] demonstrated that the Pd-catalyzed 
monoarylation of geminal bis(boranates) took place with inversion of configuration. Our work 
demonstrated the first example of a stereospecific secondary alkyl Suzuki reaction employing an 
unactivated and undirected nucleophile. This research enabled the use of (R)-sBuBF3K, which is the 
simplest optically active secondary alkylboron nucleophile. Therefore, transmetallation to Pd (II) in 
this process is not biased by any electronic coordination, and should most closely represent the 
fundamental mechanism of transmetallation for secondary alkylboron nucleophiles. Our observation 
that unactivated secondary alkyltrifluoroborates, without directing from inter/intramolecular 
coordination, undergo transmetallation to Pd (II) with inversion is also consistent with previous 
reports from Kalbalka[46] and Aggarwal[47] in which unactivated secondary alkylboron reagents 
undergo electrophilic substitution with clean inversion. 
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Figure 3-1. a) 2 Pathways Leading to Invertive and Retentive Transmetallation; b) Process of 
Transmetallation via Invertive SE2 pathway 
 
Most studies of the mechanism of alkylboron transmetallation have focused on use of sp2 
carbon nucleophiles.  Therefore, it was unclear how these studies relate to transmetallation of sp3 
carbon nucleophiles in which a stereoinvertive or stereorentive SE2 process is possible. To explain 
the stereoinvertive and stereoretentive mechanism, two transition state structures have been 
proposed[27] (Figure 3-1a). The stereoretentive transmetallation pathway can be rationalized via a 
4-member SE2 mechanism with intramolecular coordination, analogous to that described for 
transmetallation of sp2 carbon nucleophiles. Stereoinvertive transmetallation requires a bi-pyramidal 
transition state where the palladium complex reacts with the alkylboron compound via an SE2 


































3.2 Mechanistic Probes of Stereoinvertive Transmetallation. 
 
 








Figure 3-4. Suzuki Cross-Coupling Reaction of Chlorobenzene with a) Potassium trans-2-
Methylcyclopent-2-yltrifluoroborate b) Potassium cis-2-Methylcyclopent-2-yltrifluoroborate 
 
Our first work was to probe this SE2 pathway with experiment. Here we designed 4-tert-
butylcyclohex-1-yl trifluoroborates as our model nucleophile. Because of the large steric bulk of 
tert-butyl group, the chair configuration is inhibited from flipping, so that the tert-butyl group is 
frozen in an equatorial position. This research was conducted with a mixture of potassium cis/trans 










Inversive path is blocked,
with slow transmetalation







































excessive phenyl chloride (5.0 equiv) was used to guarantee all the nucleophiles will be involved. 
Seven parallel reactions were conducted at same time and stopped at different times. For analysis, 
each reaction was treated with oxone solution (acetone/water) to oxidize the remaining cis/trans 
BF3K (15) to easily tracked 4-(tert-butyl)cyclohexan-1-ol (17). The cis/trans product (16) and 
alcohol (17) were traced by comparing the retention time of the isolated commercial available 
diastereomers (cis/trans-16) via GC. We found that the rate of reaction for the cis diastereomer (cis-
15) is significantly faster than the reaction for the trans diastereomer (trans-15), and yielded product 
via the stereoinvertive pathway (tran-16) (Figure 3-2). This observation is consistent with the 
proposed SE2 pathway, in which transmetallation of trans-15 should be less favored due to steric 
hindrance imparted by the axial C-H bonds, while transmetallation of cis-trifluoroborate (cis-15) 
should be more favored with the open site for SE2 pathway (Figure 3-3). Furthermore, we also 
observed that as the consumption of less favored trans-trifluoroborate (trans-15) occurred over 24 
hours, only trans-phenyl product (trans-16) was formed. This suggests that both inversion and 
retention pathways are viable, and that if the stereoinvertive pathway is blocked, the stereoretentive 
process can occur. This provides an explanation for the stereoretentive transmetallation observed by 
Molander using trans-2-methyl-cyclohex-1-yltrifluoroborate, in which the stereoinvertive pathway 
is blocked (Figure 3-3). [16] Another observation from our another experiment is consistent with this 
proposal (Figure 3-4). The cross-coupling reaction between chlorobenzene with potassium trans-2-
methyl cyclopent-2-yl trifluoroborate (trans-18), where the trans-methyl group might block the 
stereoinvertive pathway, yields three isomers. 9% trans-19 product forms via the stereoretentive 
pathway, while the two major isomers, cis-19 (18%) and cis-20 (50%), form via a stereoinvertive 
pathway. In contrast, the coupling with cis-18 occurs with clean inversion. 
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3.3 Correlation between Stereoselectivity and Parameterized Phosphine Ligand  
 
Figure 3-5. Variation of Enantiomeric Excess (% ee) According to a) Electrophiles and b) Ligands 
 
The studies described in Section 3.2 demonstrate that steric effects can dramatically impact 
the transmetallation pathway.  We next sought to investigate electronic influences on 
transmetallation. When aryl chlorides with different electronic properties were employed in a model 
reaction using enantioenriched sec-butyltrifluoroborate, we observed a decrease in preference for 
the stereoinvertive pathway for more electron-deficient aryl electrophiles.  The change in 
stereospecificity correlates well to Hammett spara values (Figure 3-5a).  When the phosphine ligand 
was varied in cross-coupling reactions using a single aryl electrophile, we observed a dramatic 
change in % ee from -79% to +65%. No correlation was evident between the cone angle of ligand 
and the observed stereoselectivity (Figure 3-5b). These observations suggested a relationship 
between the selectivity and electron density of the palladium complex, and inspired the use of 
statistical models of parameterized phosphine properties to better understand the selectivity. 
Sigman explored and developed a novel pathway to probe and understand reaction mechanism 



















































his work, reaction outcomes were correlated mathematically with quantifiable reaction 
parameters.[48] Recently, Sigman reported a correlation of parameterized phosphine ligand 
properties to regio-selectivity in oxidative addition of palladium in Suzuki cross-coupling 
reaction.[48c] Furthermore, this method has also been applied on elucidating the competing reaction 
pathways in an asymmetric fluorination reaction.[48b] These works provided the key to unlock the 
linkage between ligands and our observation.  
 
 
Figure 3-6. Energetic Diagram of 2 Pathways 
Here, to quantitatively describe stereo-selectivity, we proposed a simultaneous competing 
process of both invertive and retentive transmetallations, so that the selectivity could be described 
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Figure 3-7. a) Enantiospecificity of Suzuki Cross-Coupling Reaction with Enantioenriched 
Potassium (R)-sec-Butyltrifluoroborate; b) Yield of Branched Product (21) and Linear Product (22); 
c) Possible Process of Isomeric Racemization 
 
Potassium (R)-sec-butyltrifluoroborate (98 % e.e.) was used as our 1st model, and the 
optimized cross-coupling conditions from Figure 2-2 were employed with various ligands. Results 
from this model showed that electron-deficient ligands (such as L1, L2) favor retention and 
electron-rich ligands (L7-9) favor inversion, which were consistent with our expectation (Figure 3-
7a). However, most ligands showed poor stereoselectivity (∆∆G < 0.5 kcal/mol, es < 40), which 
suggested either a coincidentally small ∆∆G for the stereoinvertive and stereoretentive 
transmetallation pathways, or the existence of another pathway through which enantiopurity could 
be lost. For most ligands that gave poor stereoselectivity, extensive formation of linear by-product 
was also observed, which suggested that b-hydride elimination/reinsertion sequences may be 
responsible for the erosion of enantiopurity (Figure 3-7c). More isomerization (>50%) was 
observed in the cases with small ligands (L5, L6, L15s, L12s), while larger ligands (L8, L9, L12s) 
appear more likely to inhibit b-hydride elimination, thus yielding less isomerized and racemized 























































Figure 3-8. Phosphine parameterization. A) Workflow of parameter generation and statistical 
modeling. B) Application of phosphine parameterization to ligand optimization of the reaction 
shown in Figure 3-7. +% ee = net retention, -% ee = net inversion. 
 
In collaboration with Sigman’s group, we have employed statistical models to describe 
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was first used to analyze the stereoselection and the proclivity of β-H elimination with the 
properties of phosphine ligands. Here, the workflow[48-51] was initiated from a molecular 
mechanisms (MM) conformational search, by which we could identify low energy conformers. 
After this, DFT work was used to optimize the conformers geometrically and collect the parameters. 
Consequently, four descriptors were defined to describe the properties of ligands, which are 
maximum/minimum value, lowest energy conformer values and the Boltzmann weighted averages. 
These parameters were considered comprehensively in the regression analysis (Figure 3-8A). In the 
model with potassium (R)-sec-butyltrifluoroborates, we observed a modest correlation of the 
minimum width B1 of the phosphine ligand to the branched:linear ratio. This suggested that larger 
ligands with higher width B1 may inhibit the occurrence of β-H elimination and yield less linear 
isomers, and vice versa (Figure 3-8B).  
Since an intuitive relationship between stereoselection and electron property of ligands was not 
apparent, the use of new ligand parameters was investigated. As an easily computable measurement 
to represent the ligand’s electric property, the minimum molecular electrostatic potential of the 
phosphorus lone pair electrons (Vmin) was found to correlate with the classical Tolman electronic 
parameter.[52] Using this parameter, it became clear that more electron-rich ligands (more negative 
Vmin) favor stereoinversion while more electron-deficient ligands (less negative Vmin,) favor 
stereoretention (Figure 3-8B). The bulky and electron-rich PAd3 (L9), reported by Carrow[53], 
shows greatest stereoinvertive preference and highest branched:linear ratio in this system. Based on 
the data, we proposed that large, electron-deficient ligands should selectively promote the 
stereoretentive pathway.  To test this proposal, modification was made to diphenyl Buchwald’s 





Figure 3-9. Initial Investigation (16 Ligands) of Enantiospecificity of Suzuki Cross-Coupling 
Reaction Using Enantioenriched Potassium (R)-4-Phenylbut-2-yltrifluoroborates 
 
To reach a better correlation by avoiding the erosion on ee from isomerization, we adopted a 
second nucleophile, potassium (R)-4-phenylbut-2-yltrifluoroborate ((R)-12’, 96.3-97.0 % e.e.), for 
the model. With a longer and non-symmetrical carbon chain, a larger range of outputs was observed 
for 12, although rearrangement did still occur. In this study, we removed the ligands L5, L6, L12s, 
which primarily gave isomerized products in our first model system, and added two new ligands 
(L16s, L17s) to explore the effect of the phosphine substituents. As in our first model, we attributed 
the concurrent loss of enantiopurity and occurrence of rearrangement with a competing b-H 

















































































































































































model, but showed a wider range of data points, while following a similar relationship between 




Figure 3-10. Investigation (16 Initial Ligands + 8 New Ligands) of Enantiospecificity of Suzuki 


























































































































































































































































































Our next efforts focused on investigation of analogues of di-phenyl Buchwald ligands to 
validate the observed trends, and to find a new ligand that better supported the stereoretentive 
transmetallation pathway. Based upon our initial data, we predicted that more electron-deficient 
ligands would exhibit enhanced selectivity for stereoretention. Using commercially available di-
phenylXPhos (S15), we observed similar enantiospecificity to reactions using di-phenylSPhos, but 
higher yields and less rearrangement. We also prepared new ligands (L1s, L8s, L10-14) with 
different aryl substituents on phosphorus. Results given by those ligands were not only consistent, 
but also astonishing. Compared to di-phenylSPhos (L2), ligands (L8s, L12) with electron-donating 
groups on the phosphine led to eroded enantiospecificity; while ligands (L10, L11, L13, L14) 
modified by adding -CF3 groups to the phenyl ring afforded higher enantiospecificity. All these 
results implied a strong correlation between the stereoselectivity and electron density on phosphine 
(Figure 3-10). Highest selectivity for stereoretentive transmetallation (up to 90% ee) and least 
isomerization (up to 69:1) were observed using modified ligands L11 and L14 in model with 
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Figure 3-11.  (a) Correlation with 24 Ligands; (b) Interpretation of Electronic and Steric Parameters; 
(c) Correlation with 20 Ligands (B1Boltz >4). Boltzmann-weighted average across the conformers for 
the average energies of the three P-C s* antibonding orbitals in each phosphine. ELP(P)Boltz: 
Boltzmann-weighted average of the energy of the phosphorus lone pair orbital. Sterimol B1Boltz is 
the least width and Sterimol Lminconf is the length of the lowest-energy conformer as seen from 
opposite the P substituents. Red points in the diagram: validation data (EV) not used in the model 
training. LOO = leave-one-out validation score. K-fold: average leave-three-out cross-validation 
score. 
	
Using the second model, the parameterized electronic and steric properties of phosphine 
ligands were employed in a multivariate regression analysis of the experimentally observed 
selectivities. The average energy of the P−C antibonding orbitals, Eσ*(P-C), represents the proclivity 
of π-back bonding; and the energy of the lone pair orbital of phosphorus, ELP(P), is a measure of the 
ligand’s σ-donation capability (Figure 3-11B). Mechanistically, this model suggests that the 
0.62 Eσ*(P–C)avg
Boltz – 1.2 ELP(P)Boltz
data set without ligands with 
B1Boltz < 4 (20 ligands)
ΔΔG‡ = 1.5 +
C



















ΔΔG‡ measured in kcal/mol
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stereoinvertive pathway is favored by strong σ-bond donating interaction from ligands, which result 
in greater electron density on palladium. Conversely, the stereoretentive pathway is favored by π-
back bonding interaction between a filled d orbital and the P-C anti-bonding orbital of the ligand 
(Figure 3-11A). Including two steric descriptors such as B1 and L improves the model fit by 
treating the competitive β-hydride elimination that occurs using smaller ligands and decreases the 
observed specificity. This becomes evident when the four smallest ligands in this dataset are 
removed from the analysis, which results in an excellent correlation using just the two electronic 
descriptors with the experimentally observed stereochemical outcomes (Figure 3-11C).     




4. A Study on Ligand-Directing-Stereodivergent Suzuki Cross-Coupling 
Reaction 
4.1 Background 
The development of new reactions that precisely control the stereochemistry of products is an 
ongoing challenge of organic synthesis.  In stereospecific Suzuki cross-coupling reactions, one of 
the most essential challenges is preparation of enantioenriched alkyl boron nucleophiles. Classical 
methods to access inactivated enantioenriched alkyl boron nucleophiles have been described by 
Brown,[41a] Matteson[42] and Aggarwal[47] etc., which have subsequently been adopted in our 
research. A major limitation that results from use of a single enantiomer in stereospecific reactions 
is its dependence on the initial configuration of starting nucleophile.  In most asymmetric synthesis, 
absolute stereochemistry can be controlled through the proper choice of enantiomer of the 
supporting ligand. However, it is difficult to access both possible enantiomeric products using a 
single-enantiomer reagent through stereospecific cross-coupling reactions. In 2010 and 2011, 
Suginome reported one approach to control absolute stereochemistry, which involved manipulation 
of intra/intermolecular coordination using enantioenriched α-(acylamino)benzylboronate(Bpin).[26] 
Our work in chapter 3 shows that through proper selection of ligands the selectivity between 
inversion and retention pathways may have up to 5.0 kcal/mol energy difference (from 94 % e.e. to 
-87 % e.e.). Therefore, using this system, we expected to be able to develop a general catalytic 
system that enabled access to both enantiomers of products from a single-enantiomer alkylboron 
nucleophile. 
 














Conditions A Conditions BConditions A or B
Conditions A1 (stereoretention)
L = L 11, Cs2CO3 (3 equiv),





L = PAd3 (L 9)
Pd NH2




L = L 14, K2CO3 (3 equiv),





X = Cl 
conditions B
84% yield
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X = Cl 
conditions A2
69% yield 
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X = Br 
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91% ee (95% es)
(S)-23i
X = Cl 
condition B
84% yield 
87% ee (91% es)
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Figure 4-1. Stereodivergent Pd-catalyzed Cross-Coupling Reactions with Enantioenriched 
Alkylboron Nucleophiles. 
 
The stereochemical investigations of secondary alkylboron on transmetallation in Suzuki 
reaction demonstrated that both enantiomers of a cross-coupling product could be selectively 
accessed through use of a single enantioenriched alkylboron reagent with the proper selection of the 
phosphine ligand. From the model, strong π-accepting ligands, di-(3,5-bis-CF3)phenylSphos (L 11) 
and di-(3,5-bis-CF3)phenylXphos (L 14), preferentially favored stereorentive pathway. On the other 
hand, strongly σ-donating ligand PAd3 (L 9) is a significant upgrade from PtBu3 (L 8) in both 
reactivity and stereospecificity favoring the stereoinvertive pathway. The basic conditions originally 
(R)-23j
X = Br 
conditions A1
46% yield
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optimized for PtBu3 are applicable with these three new ligands. Excellent enantiodivergence could 
be achieved using these systems (Figure 4-1). These systems could be readily applied to coupling 
reactions involving electron-deficient aryl electrophiles (23f, 23i). In the stereoretentive variant, 
aryl bromide, and Cs2CO3 were used alongside ligand L11 for a higher yield; while in the 
stereoinvertive variant, use of PAd3 at 60-80 ºC led to significantly enhanced enantioselectivity 
compared to use of PtBu3. For electron-neutral or electron-rich aryl chloride (23c, 23e, 23h), di-
(3,5-bis-CF3)phenylXPhos (L14) performed better. In this case, an additional equivalent of ligand 
to palladium was essential. Difficult, electron-rich electrophiles successfully underwent cross-
coupling reactions  under these conditions (23a, 23d). 4-Haloanisoles were observed to be inert 
using the retentive ligands, even when a double loading of Pd with ligand was applied. However, 
using 4-anisole triflate, a decent yield was achieved. We also used 4th generation (N-methyl) 
Buchwald precatalyst to avoid a by-product from competing C-N bond-formation between anisole 
and carbazole, which is released form the precatalyst. Using Aggarwal’s method, various 
enantioenriched nucleophiles were applied with decent yield and high enantioselectivities (23j, 23k, 
23l). Use of postassium trans-2-methyl-cyclopent-1-yl trifluoroborate as a nucleophile was only 
successful using stereoretentive ligand L14.  This is constituent with the stereoinvertive pathway 
being sterically blocked in this substrate.  Compared with PtBu3 (L 8), PAd3 (L 9) was significantly 
better for heteroaryl halide (26a, 26b, 26c) couplings. In addition to enantioenriched nucleophiles, 
we also investigated use of diastereoenriched nucleophiles (24a, 24b) in these reactions.  High 
diasteroselectivity could be achieved simply by changing the ligand. A change in selectivity from 
30:1 to 1:5 was achieved by simply changing the ligand, which corresponds to a 3.6 kcal/mol 
difference in activation energy. 
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 5. Conclusion  
 
In summary, a palladium-catalyzed Suzuki cross-coupling reaction of aryl halide with 
unactivated secondary alkyl boronic acid and trifluoroborates has been studied. Via the application 
of Buchwald precatalyst, and the optimized condition, we successfully obtained the branched 
product in high yield, while suppressing isomerization. We demonstrated the application of this 
method in a broad substrate scope. With enantioriched alkyltrifluoroborates, we demonstrated that 
the cross-coupling took place via a SE2 invertive pathway by Pd/PtBu3 specifically.  
Later, we carried out an extensive investigation of stereoselectivity with ligands. In the 
collaboration with Sigman’s group, we established a correlation between the stereoselectivity and 
the electronic properties of phosphine ligand. This statistical study was used to help predict and 
construct ligands to favor each pathway, which was developed into a ligand-directed 
stereodivergent Suzuki cross-coupling reaction. This system was successfully applied to a broad 
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7.1. General Reagent/ Analytical Information 
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized) 
was also purchased from VWR. These solvents were transferred to separate 20 L solvent-
delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. Water used 
in Suzuki reactions was distilled and degassed prior to use. Reagents and solvents were used as 
received unless otherwise noted. Flash chromatography was performed using Silicylcle silica gel 
(ultra pure grade).  
All compounds were characterized by 1H NMR and 13C NMR spectroscopy. Copies of the 
1H and 13C spectra for all new compounds can be found at the end of the Supporting Information. 
All previously unreported compounds were additionally characterized by high resolution MS. 
Nuclear Magnetic Resonance spectra were recorded on a Varian 300 or 500 MHz instrument. All 
1H NMR experiments are reported in δ units, parts per million (ppm), and were measured relative 
to the signals for residual chloroform (7.26 ppm), dimethyl sulfoxide (2.50 ppm) or residual 
acetone (2.05 ppm). All 13C NMR spectra are reported in ppm relative to deuterochloroform 
(77.23 ppm), dimethyl sulfoxide (39.52 ppm) or residual acetone (29.84 ppm), and were obtained 
with 1H decoupling. High-resolution MS analyses were performed on an Agilent 6520 Q-TOF 
instrument. All GC analyses were performed on a Shimadzu GC-2010 gas chromatograph with 
an FID detector using a 25 m x 0.20 mm capillary column with cross-linked methyl siloxane as 
the stationary phase. All GC yields were calibrated using dodecane or tetradecane as an internal 
standard. Chiral GC analyses were performed using a 30 m x 0.32 mm chiral column (Rt®-
βDEXsm from Restek). Chiral HPLC analyses were performed on a Shimadzu LC-20AB 
prominence liquid chromatograph. Polarimetry measurements were performed using an Anton 
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Paar-MCP 100 modular circular polarimeter.  
 
7.2. General Procedural Information and Compound Characterization Data 
Formation of optically active secondary alkyltrifluoroborates  
H.C. Brown’s protocol[1a] was employed to prepare (R)-sec-butyl trifluoroborates ((R)-9) 
 
















BF3 • Et2O (1% equiv)























2. RhCl3 (10 mol %)
    Al2O3, H2 (130 psi)



































Potassium trans-2-methylcyclopentyl trifluoroborate (trans-
18).[1c] 
 
A 100 mL oven-dried 2-neck round bottom flask was 
fitted with a condenser and a rubber septum. The apparatus was evacuated (ca. 200 mtorr) and 
backfilled with argon 4 times. 2-methylcyclopentene (2.73 g, 33.3 mmol), dichloromethane (20 
mL) and HBBr2-SMe2 (33.4 mL, 33.3 mmol) were injected via syringe. The reaction mixture 
was heated to reflux overnight. The reaction mixture was allowed to cool to rt, then cooled to 0 
oC, at which point, water (10 mL) and Et2O (20 mL) were injected via syringe. The resulting 
mixture was then extracted with Et2O (40 mL x 2). The organic extracts were combined and 
washed with water (30 mL). The resulting crude boronic acid was then dissolved in MeOH (67 
mL) and cooled to 0 ºC. KHF2 (24 mL 4.5 M in water) was added dropwise, and then the 
reaction mixture was allowed to warm to rt. After stirring for 1 h, the solution was concentrated 
in vacuo. The resulting white solid was then dried under high vacuum overnight. The crude solid 
was purified by continuous Soxhlet extraction with acetonitrile (100 mL). The resulting solution 
was concentrated under reduced pressure. The solid was recrystallized from ether/hexane, 
yielding a white crystalline solid (4.33 g, 22.8 mmol, 68% yield). 1H NMR (300 MHz, DMSO): 
δ 1.67-1.50 (m, 2H), 1.50-1.15 (m, 4H), 0.89 (d, J = 6.2 Hz, 3H), 0.98-0.78 (m, 1H), 0.00 (br, 
1H) ppm. 13C NMR (75 MHz, DMSO): δ 36.9, 36.6, 29.4, 25.7, 22.1 ppm. 11B NMR (96 MHz, 












1H NMR (300 MHz, CDCl3): δ 2.33-2.19 (m, 1H), 1.78-1.59 (m, 4H), 1.52-
1.40 (m, 1H), 1.35-1.19 (m, 2H), 1.25 (s, 12H), 0.91 (d, J=7.0 Hz, 3H) ppm. 
 
Potassium cis-2-methylcyclopent-1-yl trifluoroborate.  
1H NMR (300 MHz, acetone-D6): δ 2.04-1.91 (m, 1H), 1.65-1.43 (m, 4H), 
1.43-1.26 (m, 1H), 1.26-1.08 (m, 1H), 0.85 (d, J=6.9 Hz, 3H), 0.70 (br, 1H) 
ppm. 13C NMR (75 MHz, acetone-D6): 36.74, 36.68, 27.57, 25.50, 18.95 ppm. 11B (96 ppm, 














RhCl3 (10 mol %),

















Procedure of oxidation of potassium secondary alkyl trifluoroborate to corresponding alcohol. [2] 
 
The potassium alkyltrifluoroborate (0.1 mmol) was added to an 8 mL culture tube. Acetone 
(0.5 mL) was added to the tube via syringe to dissolve the alkyltrifluoroborate. Then, oxone 
solution (0.5 mL, 0.2M in H2O) was added via syringe and the mixture was allowed to stir at rt 
for 10 min. HCl (0.3 mL, 0.1 M in H2O) and H2O (0.5 mL) was added to quench the reaction, 
which was then extracted with dichloromethane (2 mL x 3). The combined extracts were dried 
with anhydrous sodium sulfate and concentrated under reduced pressure.  
 
trans-2-Methylcyclopentan-1-ol.[3] Using the standard procedure 
for oxidation of alkyl trifluoroboronates to their corresponding 
alcohols, a colorless liquid (8.3 mg, 83% yield) was isolated. 1H 
NMR (300 MHz, CDCl3): δ 3.74 (q, J = 6.1 Hz, 1H), 2.0-1.84 (m, 2H), 1.84-1.45 (m, 5H) 1.27-
1.09 (m, 1H), 0.99 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 80.8, 42.9, 34.3, 31.8, 
21.6, 18.4 ppm.  
 
cis-2-Methylcyclopentan-1-ol.[3] Using the standard 
procedure for oxidation of alkyl trifluoroboronates to their 
corresponding alcohols, a colorless liquid (7.9 mg, 79% yield) 
was isolated. NMR (300 MHz, CDCl3): δ 4.10-4.03 (m, 1H), 1.91-1.45 (m, 6H), 1.43-1.31 (m, 
1H), 1.26 (br, 1H), 1.03 (d, J=6.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 76.4, 39.9, 34.8, 























Preparation of racemic 4-phenylbut-2-yl pinacolboronate with Wang’s protocol. [4] 
 
On the benchtop, 4-methyl-N'-(4-phenylbutan-2-ylidene)benzene-sulfonohydrazide (6.32 g, 
20 mmol) was added into a 500 mL oven-dried round bottom schlenk flask, which is equipped 
with stirbar. The flask was taken into glovebox, where sodium methoxide (1.19 g, 22 mmol) and 
benzyltrimethylammonium chloride (370 mg, 2 mmol) were added. Outside of the glovebox, the 
flask was connected to schlenk line, evacuated (ca. 200 mtorr) and backfilled with argon 3 times. 
Anhydrous toluene (160 mL) was injected into the flask via syringe. After 1 hour stirring under 
ambient temperature, HBpin (8.7 mL, 60 mmol, 3.0 equiv) was injected into the flask dropwise 
and stirred for an additional 15 min. The mixture was then heated to 110 ºC and refluxed for 24 
h. After the completion of the reaction (confirmed by GC), saturated aqueous NH4Cl solution 
(100 mL) was added to quench the reaction. The mixture was extracted with hexane (150 mL x 
3), and the combined organic phase was washed with brine (100 mL) and dried over anhydrous 
Na2SO4. The solvent was removed under reduced pressure, and a colorless oil (3.08 g, 59% 
yield) was isolated following column chromatography (5/95 hexane:ether).   
 















The pinacolboronate (10 mmol) was added to a 250 mL round bottom flask equipped with a 
stirbar, and MeOH or MeCN (50 mL) was injected via a syringe. Pre-prepared KHF2 aqueous 
solution (10.0 mL, 4.5 M, 45 mmol) was added to the mixture via pipet. The mixture was 
allowed to stirred at room temperature for 2 h, till no more boronate was detectable by GC. The 
solvent was removed under reduced pressure. The solid residue was extracted with acetone (20 
mL x 3). The combined extracts were filtered through a cotton plug into another round bottom 
flask. Acetone was removed under reduced pressure. The remaining residue was dissolved in 
ether (0.5-1 mL) and precipitated by addition of hexane. The precipitate was collected on a 
fritted filter funnel, and washed with hexane.  
 
General procedure for the preparation of alkylcarbamates.[6] 
 
Alkyl alcohol (100 mmol) N, N-diisopropylcarbamoyl chloride (100 mmol) were added into a 
250 mL round bottom flask containing a stirbar. Dichloromethane (100 mL) and triethylamine 
(110 mmol) were injected successively via syringe. The flask was connected to a condenser and 
heated to reflux overnight. The cooled solution was filtered by a gravity filtration, and 
concentrated under reduced pressure. The alkylcarbamate was additionally purified via column 
chromatography.  
R Me
BPin 4.5 equiv KHF2 (4.5 M, H2O)



















Using the general procedure above, a colorless oil (7.14 g, 90% yield from 
30.0 mmol alcohol) was isolated following column chromatography (95/5 hexane:ether). 1H 
NMR (300 MHz, CDCl3): δ 7.37-7.27 (m, 2H), 7.24-7.15 (m, 3H), 4.12 (t, J = 6.5 Hz, 2H), 4.25-
3.53 (br, 2H), 2.72 (t, J = 7.44 Hz, 2H), 1.98 (quintet, J=6.5 Hz, 2H), 1.22 (d, J = 6.8 Hz, 12H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 155.9, 141.7, 128.5, 128.5, 126.0, 64.1, 45.9 (br), 32.7, 
31.0, 21.2 (br) ppm. 
 
3-(thiophen-2-yl)propyl diisopropylcarbamate. 
Using the general procedure above, a colorless oil (7.72 g, 87% yield from 
33.0 mmol alcohol) was isolated following column chromatography (95/5 
hexane:ether).  1H NMR (300 MHz, CDCl3): δ 7.12 (dd, J1 = 5.1 Hz, J2 = 1.2 Hz, 1H), 6.92 (dd, 
J1 = 5.1 Hz, J2 = 3.4 Hz, 1H), 6.81 (dd, J1 = 3.4 Hz, J2 = 1.1 Hz, 1H), 4.14 (t, J = 6.4 Hz, 2H), 
4.22-3.56 (br, 2H), 2.94 (t, J = 7.0 Hz, 2H), 2.10-1.97 (m, 2H), 1.22 (d, J = 6.8 Hz, 12H) ppm. 
13C NMR (75 MHz, CDCl3): δ 155.7, 144.2, 126.8, 124.4, 123.2, 63.6, 45.9 (br), 31.2, 26.7, 21.1 
(br) ppm. HRMS: Calcd (M+H+) 270.1528; Found 270.1536.  
 
3-phenoxypropyl diisopropylcarbamate 
Using the general procedure above, a colorless oil (7.96 g, 86% 
yield from 33.0 mmol alcohol) was isolated following column 
chromatography (95/5 hexane:ether).  1H NMR (300 MHz, CDCl3): δ 7.33-7.22 (m, 2H), 6.98-
6.87 (m, 3H), 4.28 (t, J = 6.3 Hz, 2H), 4.07 (t, J = 6.4 Hz, 2H), 4.04-3.58 (br, 2H), 2.15 (quintet, 
J = 6.3 Hz, 2H), 1.20 (d, J = 6.8 Hz, 12H) ppm. 13C NMR (75 MHz, CDCl3): δ 158.9, 155.6, 
129.5, 120.7, 114.5, 64.7, 61.6, 45.8 (br), 29.2, 21.1 (br) ppm. HRMS: Calcd (M+H+) 280.1913; 






α-Methylation of 3-(thiophen-2-yl)propyl diisopropylcarbamate 
 
 
3-(5-Methylthiophen-2-yl)propyl diisopropylcarbamate.  
An oven-dried 200 mL round bottom flask containing a stirbar was 
sealed with a rubber septum. Using a needle attached to a vacuum line, 
the flask was evacuated (ca. 150 mtorr) and backfilled with argon 3 times. 3- (Thiophen-2-
yl)propyl diisopropylcarbamate (5.8 mL, 25 mmol) was then injected via syringe, and the flask 
was cooled to -78 oC in a dry ice/acetone bath. To the cooled solution, n-BuLi (16.0 mL, 32.5 
mmol, 2.0 M in hexane) was added dropwise via syringe. The reaction mixture was warmed to rt 
and stirred for an additional 1 h. MeI (2.4 mL, 37.5 mmol) was then injected via syringe, and the 
reaction mixture was stirred for an additional 1 h. Saturated aqueous ammonium chloride (50 
mL) was added to the flask slowly, and the resulting solution was transferred to separatory 
funnel. The mixture was extracted by ether (3 x 100 mL), and the combined extracts were 
concentrated under reduced pressure. A colorless oil (4.72 g, 67% yield from 25.0 mmol 
carbamate) was obtained following purification by column chromatography (95/5 hexane:ether). 
1H NMR (300 MHz, CDCl3): δ 6.60-6.52 (m, 2H), 4.13 (t, J = 6.4 Hz, 2H), 4.14-3.63 (br, 2H), 
2.85 (t, J = 7.4 Hz, 2H), 2.42 (s, 3H), 1.99 (quintet, J = 8.0 Hz, 2H), 1.21 (d, J = 6.8 Hz, 12H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 155.8, 142.0, 137.6, 124.8, 124.2, 63.7 (br), 45.7, 31.2, 
26.9, 21.1 (br), 15.3 ppm. HRMS: Calcd (M+Na+) 306.1504; Found 306.1519.  
 
Preparation of enantioenriched secondary alkyl pinacolboronate via Aggarwal’s protocol. [6] 
OCbS
1.1 equiv nBuLi (1.6 M, hexane)
1.1 equiv MeI






An oven-dried 500 mL 3-neck round bottom flask with stirbar was fitted with a condenser 
and rubber septum, and connected to a vacuum line. The apparatus was then evacuated (ca. 200 
mtorr) and backfilled with argon for 3 times. Et2O (81 mL) and (+)-sparteine (16.5 mmol) 
(TMEDA was used when preparing racemic boronate) were injected through the septum. sBuLi 
(16.5 mmol, in THF) was added dropwise over 10 mins. The flask was placed into a -78 ºC dry 
ice/acetone bath and the reaction mixture was stirred for 0.5 h. Predissolved carbamate (15 
mmol, in 6 mL ether) solution was then injected dropwise into the flask and stirred at -78 ºC for 
6 h. With the reaction mixture still at -78 ºC, predissolved MeBPin (16.5 mmol, in 27.5 mL Et2O) 
was injected dropwise and stirred for 1 h. Then, with the reaction under a positive pressure of 
argon, MgBr2 powder (16.5 mmol) was quickly added to the mixture, which was stirred for 
another 0.5 h at -78 ºC and warmed up to room temperature and additionally heated to reflux. 
The mixture was allowed to reflux for an additional 24 h, at which point, GC analysis showed 
complete consumption of the carbamate. The mixture was cooled down to room temperature and 
then cooled in a 0 ºC ice-water bath. At 0 ºC, Methanol (10 mL) was added slowly to quench the 
remaining organolithium. Then aqueous NH4Cl solution (100 mL) was added slowly to the 
mixture. Then the mixture was transferred to a 500 mL separatory funnel and extracted with 
ethyl ether (100 mL x 3). The combined organic layers were washed with brine (100 mL) and 
dried by anhydrous Na2SO4. The organic layer was filtered, concentrated under reduced pressure, 
and additionally purified by column chromatography.  
 
R1 OCb
1.1 equiv sBuLi (in hexanes),
1.1 equiv (+)-sparteine,
0.18 M Et2O,
1.1 equiv R2Bpin (0.6 M in Et2O)
1.0 equiv (2.5 M in Et2O)






dioxaborolane.[6a]   
Using Wang’s protocol, [1] a colorless oil (3.08 g, 59% yield) was 
isolated following column chromatography (5/95 hexane:ether). 
 
(R)-4,4,5,5-tetramethyl-2- (4-phenylbutan-2-yl)-1,3,2-
dioxaborolane.[6a]   
Using Aggarwal’s procedure, [6a] a colorless oil (2.40 g, 9.23 mmol, 
46 % yield from 20 mmol carbamate) was isolated following 
column chromatography (5/95 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 7.33-7.24 (m, 2H), 
7.24-7.14 (m, 3H), 2.65 (t, J = 8 Hz, 2H), 1.89-1.74 (m, 1H), 1.69-1.54 (m, 1H), 1.27 (s, 12H), 
1.16-1.07 (m, 1H), 1.05 (d, J = 5.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 143.3, 128.6, 
128.4, 125.7, 83.1, 35.5, 35.5, 25.0, 24.9, 15.6 ppm. 11B NMR (96 MHz, CDCl3): 34.9 ppm. 
Optical rotation of enantioenriched product [α]25D (c 1.00, CHCl3) = -6.4 º. (Lit. [α]25D (c 1.50, 
CHCl3) = +7.2 º, (S)-4,4,5,5-tetramethyl-2- (4-phenylbutan-2-yl)-1,3,2-dioxaborolane). [6a]  
 
Potassium 4-phenylbutan-2-yl trifluoroborate.  
Using the general procedure for preparing alkyl trifluoroborates, a pale 
white solid (1.40 g, 62 % from racemic boronate) was acquired.  
 
Potassium (R)- 4-phenylbutan-2-yl trifluoroborate. 
Using the general procedure for preparing alkyltrifluoroborates, a pale 


















enantioenriched boronate) was isolated. The corresponding oxidized alcohol was analyzed as 
97.0% e.e. (in 1st run; 96.3% in 2nd run) by GC. 1H NMR (300 MHz, DMSO): δ 7.25-7.17 (m, 
2H), 7.15-7.05 (m, 3H), 2.64-2.52 (m, 1H), 2.47-2.37 (m, 1H), 1.64-1.50 (m, 1H), 1.23-1.08 (m, 
1H), 0.70 (d, J = 7.2 Hz, 3H), 0.22-0.03 (br, 1H) ppm. 13C NMR (75 MHz, DMSO): 144.7, 
128.2, 127.9, 124.8, 36.3, 35.0, 16.4 ppm. 11B NMR (96 MHz, DMSO): 4.8 ppm. 
 
 (R)-4-phenylbutan-2-ol.[6a] 
Using the standard procedure for oxidation of alkyl trifluoroboronates 
to their corresponding alcohols, a colorless liquid (11.7 mg, 78% yield) 
was isolated. 1H NMR (300 MHz, CDCl3): δ 7.35-7.25 (m, 2H), 7.25-7.15 (m, 3H), 3.82 (sextet, 
J=6.2 Hz, 1H), 2.84-2.60 (m, 2H), 1.88-1.69 (m, 2H), 1.66-1.39 (br, 1H), 1.24 (d, J=6.2 Hz) 
ppm. 13C NMR (75 MHz, CDCl3): 142.3, 128.6, 126.0, 67.7, 41.1, 32.3, 23.8 ppm. Optical 







a colorless oil (2.51 g, 60% yield 
from 15 mmol carbamate) was isolated following column 













Using Aggarwal’s procedure [6], a colorless oil (2.13 g, 71% yield 
from 10.6 mmol enantioenriched) was isolated following column 
chromatography (3/97 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 6.58-6.52 (m, 2H), 2.78 (t, 
J = 7.9 Hz, 2H), 2.43 (s, 3H), 1.91-1.77 (m, 1H), 1.72-1.55 (m, 1H), 1.26 (s, 12H), 1.13 (sextet, J 
= 7.0 Hz, 1H), 1.03 (d, J = 6.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.7, 137.0, 124.6, 
123.6, 82.9, 35.4, 29.4, 24.8, 24.7, 16.6(br), 15.4, 15.3 ppm. 11B NMR (96 MHz, CDCl3): δ 
34.69 ppm. HRMS: Calcd (M+H+) 281.1747; Found 281.1779. Optical rotation of 




Potassium (R)-4-(5-methylthiophen-2-yl) butan-2-yl 
trifluoroborate. 
Using the general procedure for preparing alkyl trifluoroborates, a 
white-yellow solid (1.12 g, 54% yield from 8.0 mmol racemic boronate) was acquired. 
 
Potassium (R)-4-(5-methylthiophen-2-yl) butan-2-yl 
trifluoroborate: 
Using the general procedure for preparing alkyl trifluoroborates, a 
white-yellow solid (1.15 g, 62% yield from 7.1 mmol enantioenriched boronate) white-yellow 
solid was acquired. The corresponding oxidized alcohol was analyzed as 95.4 % e.e. by HPLC. 
1H NMR (300 MHz, DMSO): δ 6.54-6.50 (m, 1H), 6.50-6.45 (m, 1H), 2.75-2.53 (m, 2H), 2.35 
(s, 3H), 1.65-1.50 (m, 1H), 1.24-1.13 (m, 1H), 0.68 (d, J = 7.2 Hz, 3H), 0.13 (br, 1H) ppm. 13C 
NMR (75 MNz, DMSO) δ 145.4, 135.4, 124.5, 122.8, 36.6, 29.3, 16.4, 15.0 ppm. 11B NMR (96 















Using the standard procedure for oxidation of alkyl trifluoroboronates 
to their corresponding alcohols, a colorless liquid (13.7 mg, 81 % 
yield) was isolated. 1H NMR (300 MHz, CDCl3): δ 6.59-6.56 (m, 1H), 6.56-6.53 (m, 1H), 3.86 
(sextet, J=6.2 Hz, 1H), 2.97-2.73 (m, 2H), 2.43 (s, 3H), 1.84-1.73 (m, 2H), 1.60 (br, 1H), 1.23 (d, 
J=6.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 142.8, 137.6, 124.8, 124.1, 67.4, 41.1, 26.6, 
23.8, 15.5 ppm. HRMS: Calcd (M+Na+) 193.0663; Found 193.0665. Optical rotation of 
enantioenriched product [α]20D (c 1.00, CHCl3) = -17.7 º. 
 
4,4,5,5-tetramethyl-2- (4-phenoxybutan-2-yl)-1,3,2-dioxaborolane. 
Using Aggarwal’s procedure [6], a colorless oil (2.94 g, 41 % yield 
from 26 mmol carbamate) was isolated following column 




Using Aggarwal’s procedure [6], a colorless oil (3.20 g, 45 % yield 
from 26 mmol carbamate) colorless liquid was isolated following column chromatography (95/5 
hexane:ether).1H NMR (300 MHz, CDCl3): δ 7.32-7.22 (m, 2H), 6.98-6.87 (m, 3H), 4.00 (dt, J1 
= 6.6 Hz, J2 = 1.5 Hz, 2H), 2.04-1.91 (m, 1H), 1.84-1.70 (m, 1H), 1.24 (s, 12H), 1.22-1.17 (m, 
1H), 1.04 (d, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 159.3, 129.5, 120.5, 114.8, 


















Calcd (M+H+) 277.1975; Found 277.1961. Optical rotation of enantioenriched product [α]25D (c 
1.00, CHCl3) = -12.6 º. 
 
Potassium 4-phenoxybutan-2-yl trifluoborate. 
Using the general procedure for preparing alkyl trifluoroborates, a 
white solid (1.01 g, 44 % yield from 9.0 mmol racemic boronate) was acquired. 
 
Potassium (R)-4-phenoxybutan-2-yl trifluoborate.  
Using the general procedure for preparing alkyl trifluoroborates, a 
white solid (1.64 g, 55 % yield from 11.6 mmol enantioenriched boronate) was acquired. The 
corresponding oxidized alcohol was analyzed as 97.7 % e.e. by GC. 1H NMR (300 MHz, 
DMSO): δ 7.28-7.19 (m, 2H), 6.89-6.81 (m, 3H), 3.92 (m, 2H), 1.77-1.61 (m, 1H), 1.41-1.27 (m, 
1H), 0.72 (d, J = 7.2 Hz, 3H), 0.31-0.14 (br, 1H) ppm. 13C NMR (75 MHz, DMSO): δ 159.1, 
129.3, 119.7, 114.3, 68.2, 33.3, 19.3(br), 16.9 ppm. 11B NMR (96 MHz, DMSO): δ 4.77 ppm.  
 
(R)-4-phenoxybutan-2-ol. [7] 
Using the standard procedure for oxidation of alkyl trifluoroboronates 
to their corresponding alcohols, a colorless liquid (13.6 mg, 82 % yield) 
was isolated. 1H NMR (300 MHz, CDCl3): δ 7.34-7.23 (m, 2H), 7.05-6.86 (m, 3H), 4.27-4.05 
(m, 3H), 2.23 (br, 1H), 1.95 (q, J=6.0 Hz, 2H), 1.30 (d, J=6.3 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): 158.8, 129.7, 121.1, 114.7, 66.5, 66.0, 38.3, 23.8 ppm. Optical rotation of 









Using Aggarwal’s procedure [6c], a colorless oil (5.70 g, 69% yield 
from 30 mmol carbamate) colorless liquid was isolated following 




Using Aggarwal’s procedure [6], a colorless oil (3.32 g, 81% yield from 
15 mmol carbamate) colorless liquid was isolated following column 
chromatography (98/2 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 7.33-7.23 (m, 2H), 7.23-
7.11 (m, 3H), 2.70-2.53 (m, 2H), 1.88-1.62 (m, 2H), 1.58-1.41 (m, 2H), 1.28 (s, 12H), 1.10-0.90 
(m, 1H), 0.94 (t, J=7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 143.3, 128.6, 128.4, 125.7, 
83.1, 35.8, 33.4, 25.0, 24.3, 13.8 ppm. 11B NMR (96 MHz, CDCl3): 34.6 ppm. Optical rotation of 
enantioenriched product [α]20D (c 1.00, CHCl3) = -7.7 º. (Lit. [α]25D (c 2.56, CHCl3) = -8.2 º ).[6c] 
 
Potassium (1-Phenylpentan-3-yl)trifluoroborate.[5]  
Using the general procedure for preparing alkyl trifluoroborates, the 
crude product, obtained from extraction of acetone, was dissolved in 
methanol (10 mL), which was then washed by Hexane (10 mL) for multiple times, until no 
pinacol and boronate were detectable in the hexane eluent. A white creamy solid (1.05 g, 57 % 
















Potassium (R)-(1-Phenylpentan-3-yl)trifluoroborate. [5] 
A white creamy solid (557.0 mg, 34 % yield) was obtained, using the 
same procedure above. 1H NMR (300 MHz, acetone-D6): δ 7.27-7.11 
(m, 4H), 7.11-7.00 (m, 1H), 2.62 (t, J=8.3 Hz, 2H), 1.74-1.56 (m, 1H), 1.56-1.35 (m, 2H), 1.35-
1.19 (m, 1H), 0.88 (t, J=7.3 Hz, 3H), 0.23 (br, 1H) ppm. 13C NMR (75 MHz, acetone-D6): δ 




Using the standard procedure for oxidation of alkyl trifluoroboronates 
to their corresponding alcohols, a colorless liquid (11.4 mg, 70% yield) 
was isolated. 1H NMR (300 MHz, CDCl3): δ 7.35-7.25 (m, 2H), 7.25-7.14 (m, 3H), 3.64-3.51 
(m, 1H), 2.88-2.75 (m, 1H), 2.75-2.62 (m, 1H), 1.89-1.65 (m, 2H), 1.65- 1.40 (m, 3H), 0.95 (t, 
J=7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 142.4, 128.62, 128.60, 126.0, 72.9, 38.8, 32.3, 
30.5, 10.0 ppm. Optical rotation of enantioenriched product [α]20D (c 1.00, CHCl3) = -24.2 º. (Lit. 



















To a round bottom flask under argon, ethyl 2,4,6-triisopropylbenzoate (1.45 
g, 5.85 mmol, 1.0 equiv) and (-)-sparteine (1.74 mL, 7.6 mmol, 1.3 equiv) were added followed 
by the addition of Et2O (28 mL). The solution was cooled and stirred at -78 ºC for 10 min. s-
BuLi (5.4 mL 1.4 M in cyclohexane, 7.6 mmol, 1.3 equiv) was slowly added dropwise. The 
reaction was stirred at -78 ºC for 4 h. Me3SnCl (7.6 mL, 1.0 M in hexanes, 7.6 mmol, 1.3 equiv) 
was slowly added dropwise to the solution. The reaction was stirred at -78 ºC for a further 20 
min, warmed to room temperature, and then stirred for an additional 1 h. The reaction mixture 
was diluted with H3PO4 (aq. 5%, 100 mL) and stirred for an additional 20 min. The layers were 
separated and the organic layer washed with H3PO4 (aq. 5%, 3 x 100 mL). The combined 
aqueous layers were extracted with Et2O (3 × 100 mL). The combined organic layers were dried 
over MgSO4 and concentrated under reduced pressure to give crude (S)-1-(trimethylstannyl)ethyl 
2,4,6-triisopropylbenzoate. Methanol was added to the flask (3 ml/g) and a heat gun was used to 
fully dissolve the crude product in solution. The flask was then placed in an ice bath at 0 ºC, 
MeO
Bpin
1.0 equiv (0.5 M in Et2O)








1.0 equiv (0.2 M in Et2O)
0.2 M Et2O
-78 ºC, 2 h; then 40 ºC, 2 h
0.2 M Et2O
- 95oC to rt, 1.5 h MeO
Me
Bpin














1.3 equiv nBuLi 
(1.6 M in hexanes)
0.2 M Et2O









1.3 equiv nBuLi (1.6 M in hexanes)
0.2 M Et2O
-78 oC, 2 h; then rt., 2 h
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forming white crystals, which were then filtered, and washed with cold MeOH providing pure 
(S)-1-(trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate (1.29 g, 50% yield).  
 
(R)-1-(Trimethylstannyl) ethyl 2,4,6-triisopropylbenzoate. 
To a round bottom flask under argon, ethyl 2,4,6-triisopropylbenzoate (2.65 
g, 10.65 mmol, 1.0 equiv) and (+)-sparteine (3.17 mL, 13.85 mmol,  
1.3 equiv) were added followed by the addition of Et2O (50 mL). The solution was cooled and 
stirred at -78 ºC for 10 min. s-BuLi (9.9 mL, 1.4 M in cyclohexane, 13.85 mmol, 1.3 equiv) was 
slowly added dropwise. The reaction was stirred at -78 ºC for 4 h. Me3SnCl (13.85 mL, 1.0 M in 
hexanes, 13.85 mmol, 1.3 equiv) was slowly added dropwise to the solution. The reaction was 
stirred at -78 ºC for 20 min, warmed to room temperature, and then stirred for an additional 1 h. 
The reaction mixture was diluted with H3PO4 (aq. 5%, 200 mL) and stirred for an additional 20 
min. The layers were separated and the organic layer washed with H3PO4 (aq. 5%, 3 x 150 mL). 
The combined aqueous layers were extracted with Et2O (3 x 200 mL). The combined organic 
layers were dried with MgSO4 and concentrated under reduced pressure to provide crude (R)-1- 
(trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate. Methanol was added to the flask (3 ml/g) and 
a heat gun was used to fully dissolve the crude product in solution. The flask was then placed in 
an ice bath at 0 ºC, forming white crystals, which were then filtered and washed with cold 
methanol to give pure (R)-1-(trimethylstannyl)ethyl-2,4,6-tri-isopropylbenzoate (2.43 g, 52% 
yield).  
	
(S)-2-(1-(4-Methoxyphenyl) ethyl)-4,4,5,5-tetramethyl-1, 3, 2-
dioxaborolane. 
	 80	
A solution of (R)-1-(trimethylstannyl)ethyl-2,4,6- 
triisopropylbenzoate (2.4 g, 5.5 mmol, 1.3 equiv) in a Schlenk flask was dissolved in anhydrous 
Et2O (27.5 mL) under an atmosphere of argon. The reaction mixture was cooled to –78 °C. n-
BuLi (2.2 mL, 2.5 M in hexanes, 5.5 mmol, 1.3 equiv) was added dropwise to the reaction 
mixture at -78 °C. The reaction mixture was stirred for 1 h at - 78 °C. 4-methoxyphenylboronic 
acid pinacol ester (0.5 M in anhydrous Et2O, 0.99 g, 4.23 mmol, 1.0 equiv) was then added 
dropwise to the reaction mixture at –78 ºC. The reaction mixture was stirred at –78 ºC for 30 min 
(the pale-yellow solution loses its color upon addition of the boronate). The reaction mixture was 
removed from the cooling bath and stirred at 40 ºC for 2 h. The reaction mixture was filtered 
through silica (~10 mm depth, wetted with Et2O) using a filter frit connected directly to an oven-
dried receiving vessel, to give a colorless to pale yellow translucent solution. The silica was 
washed with Et2O, the filter frit was removed, and the solvent was removed under reduced 
pressure to give the crude (S)-2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-





A solution of crude (S)-2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-  
tetramethyl-1,3,2-dioxaborolane (1.7 g, 4.23 mmol, 1 equiv) and chloroiodomethane (0.93 ml, 
12.7 mmol, 3 equiv) was dissolved in anhydrous Et2O (30 ml) under argon. The solution was 
cooled to -95 ºC (MeOH/N2 (l)). n-BuLi (5 mL, 2.5 M in hexanes, 12.5 mmol, 2.95 equiv) was 
added dropwise and the stirring was continued at -95 ºC for 10 min. The reaction mixture was 
	 81	
removed from the cooling bath and stirred at room temperature for 1 h. The reaction mixture was 
filtered through silica (~10 mm depth, wetted with Et2O), using a filter frit connected directly to 
an oven-dried receiving vessel, to give a colorless to pale yellow translucent solution. The silica 
was washed with Et2O, the filter frit was removed, and the solvent was removed under reduced 
pressure to give the crude (R)-2-(2-(4-methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (1.58 g, crude).  
 
2-((2R, 4R)-4-(4-Methoxyphenyl)pentan-2-yl)-4, 4, 5, 5-
tetramethyl-1,3,2-dioxaborolane. 
A solution of crude (S)-1-(trimethylstannyl)ethyl-2,4,6- 
triisopropylbenzoate (2.2 g, 0.2 M in ether, 4.97 mmol, 1.3 equiv) was added to a Schlenk 
reaction mixture under an atmosphere of argon. The reaction mixture was cooled to - 78 °C. n-
BuLi (1.5 mL, 2.5 M in hexanes, 3.8 mmol, 1.30 equiv) was added dropwise to the reaction 
mixture at -78 °C. The reaction mixture was stirred for 1 h at –78 °C. (R)-2- (2-(4-
methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.5 M in anhydrous Et2O, 1.58 
g, crude (3.8 mmol, 1.0 equiv) was then added dropwise to the reaction mixture at –78 °C. The 
reaction mixture was stirred at -78 °C for 30 min (the pale-yellow solution loses its color on the 
addition of the boronate). The reaction mixture was removed from the cooling bath and stirred at 
room temperature for 2 h. The reaction mixture was filtered through silica (~10 mm depth, 
wetted with Et2O), using a filter frit connected directly to an oven-dried receiving vessel. The 
silica was washed with Et2O, the filter frit was removed, and the solvent was removed under 
reduced pressure to give the crude 2-((2R,4R)-4-(4-methoxyphenyl)pentan-2-yl)-4,4,5,5-
tetramethyl-1,3,2- dioxaborolane (0.42 g, 1.37 mmol). A colorless oil (420 mg, 1.37 mmol, 33 % 
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over 3 steps) was isolated following column chromatography (0-5% ether in hexane). 1H NMR 
(300 MHz, CDCl3): δ 7.10 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H), 2.71 (q, J = 
7.3 Hz 1H), 1.69 (m, 1H), 1.45 (m, 1H), 1.27-1.10 (m, 16H), 0.92 (s, 3H) ppm. 13C NMR (75 
MHz, CDCl3): δ 157.8, 140.4, 128.1, 113.8, 83.0, 55.4, 42.6, 38.2, 25.0, 24.9, 22.3, 15.9 ppm. 
11B NMR (96 MHz, CDCl3): δ 34.79 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) 




Using the general procedure for preparing alkyl trifluoroborates, a 
white solid (310.4 mg, 64.3% yield from 1.70 mmol boronate) was obtained. 1H NMR (300MHz, 
DMSO-d6): δ 7.05 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 3.70 (s, 3H), 2.70 (sextet, J = 
6.9 Hz, 1H), 1.52-1.37 (m, 1H), 1.12-1.00 (m, 1H), 1.02 (d, J = 6.9 Hz, 3H), 0.60 (d, J = 7.1 Hz, 
3H), 0.23-0.08 (br, 1H) ppm. 13C NMR (75 MHz, DMSO-d6): δ 156.8, 142.2, 127.5, 113.3, 54.9, 




Using the same procedure as above, but with (R)-1- 
(trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate, a colorless oil (1.06 mg, 3.47 mmol,  
43% over 3 steps) was isolated following column chromatography (0-5% ether in hexane). 1H 
NMR (300MHz, CDCl3): δ 7.11 (d, J = 8.8Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H), 2.75 
(q, J = 7.3 Hz 1H), 1.76 (m, 1H), 1.44 (m, 1H), 1.22 (m, 16H), 0.94 (s, 3H) ppm. 13C NMR (75 










Using the general procedure for preparing alkyl trifluoroborates, a 
white solid (360.7 mg, 50.8% yield from 2.50 mmol boronate) was obtained. 1H NMR (300 
MHz, acetone-D6): δ 7.08 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 3.73 (s, 3H), 2.84 (m, 
1H), 1.74 (app. dddd, J1 = 4.8 Hz, J2 = 4.6 Hz, J3 = 4.4 Hz, 1H), 1.20 (m, 1H), 1.12 (d, J = 7.0 
Hz, 3H), 0.73 (d, J = 7.1 Hz, 3H), 0.15 (br, 1H) ppm. 13C NMR (75 MHz, acetone-D6): δ 158.9, 
142.9, 129.4, 114.6, 55.9, 44.2, 38.3, 25.0, 17.0 ppm. 11B NMR (96 MHz, acetone-D6): δ 5.68 
ppm. 
 
Preparation of diphenylSPhos derivatives 
 
 
2'-bromo-2, 6-dimethoxy-1, 1'-biphenyl.[9] 
An oven-dried 250 mL 2-neck round bottom flask was fitted with a 
rubber septum and connected to a vacuum line. This apparatus was 
evacuated (ca. 200 mtorr) and back-filled with argon for 4 times. 
1,3-dimethoxybenzene (2.9 mL, 22.0 mmol, 1.0 equiv) and THF (51 mL) were injected into the 
MeO OMe 1.1 equiv nBuLi (1.6 M, hexane)0.43 M THF
1.1 eq.






1.05 equiv nBuLi (1.6 M, hexane)
0.4 M THF




flask. The flask was cooled to 0 oC in an ice bath. n-BuLi (13.9 mL, 22.0 mmol, 1.58 M in 
hexane, 1.0 equiv) was injected dropwise over 5 min. The mixture was allowed to stir at 0 oC for 
5 additional minutes and then stirred at room temperature for another 3.5 h. The mixture was 
then re-cooled to 0 oC, and 1-bromo-2-chlorobenzene (2.34 mL, 22.0 mmol, 1.0 equiv) was 
injected via syringe over 15 min. The mixture was allowed to stir at 0 oC for another 15 min, at 
which time, methanol (0.5 mL) was added dropwise to quench the reaction. The crude reaction 
mixture was poured into a separatory funnel contained water (100 mL) and extracted with ethyl 
acetate (50 mL x 3). Combined the organic phases were concentrated under reduced pressure. 
The crude oil was purified via recrystallization from ethyl ether/methanol, and washed with 
methanol (5 mL x 3). A slightly yellow crystal (4.43 g, 69% yield) was obtained. 1H NMR (300 
MHz, CDCl3): δ 7.70 (dd, J1 = 7.9 Hz, J2 = 0.9 Hz, 1H), 7.43-7.33 (m, 2H), 7.30-7.19 (m, 2H), 
6.70 (d, J = 8.4 Hz, 2H), 3.77 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.9, 136.3, 132.5, 
132.5, 129.6, 128.8, 127.1, 125.4, 119.1, 104.3, 56.2 ppm.  
 
 
Diaryl derivatives of (2',6'-dimethoxy-[1,1'-biphenyl]-2-yl) 
diphenylphosphine. 
2'-bromo-2,6-dimethoxy-1,1'-biphenyl (586.0 mg, 2.0 mmol, 1.0 
equiv) was added to an oven-dried round bottom flask. The flask 
was fitted with a rubber septum and evacuated (ca. 200 mtorr) and back-filled with argon 4 
times. THF (5 mL) was injected into the flask via syringe. The flask was cooled to -78 ºC, and n-
BuLi (1.37 mL, 2.1 mmol, 1.52 M in hexane, 1.05 equiv) was added to the mixture over 10 min. 






chloride derivative (2.0 mmol, dissolved into 2 mL THF, 1.0 equiv) was injected into the mixture 
dropwise via syringe. The mixture was allowed to stir at -78 ºC for 1 h, and then allowed to 
warm to rt where it was stirred for an additional 1.5 h. The reaction mixture was then quenched 
by methanol (0.5 mL) and dissolved into ethyl acetate (10 mL). The solution was then passed 
through a pad of silica gel, eluting with ethyl acetate (20 mL). The solvent was then removed 




Using procedure above, a slightly yellow crystal (898.6 mg, 67% 
yield) was isolated following column chromatography (95/5, 
hexane/ether). 1H NMR (300 MHz, CDCl3): δ 7.82 (s, 2H), 7.62 
(d, J = 6.1 Hz, 4H), 7.52 (t, J = 7.5 Hz, 1H), 7.39-7.27 (m, 3H), 7.05 (dd, J1 = 7.7 Hz, J2 = 4.0 
Hz, 1H), 6.56 (d, J = 8.4 Hz), 3.56 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 142.5, 142.0, 
141.1, 140.8, 134.3, 133.1, 131.9, 130.7, 128.5, 125.1, 122.7, 121.4, 118.2, 117.83, 103.7, 55.5 
ppm. 31P NMR (121 MHz, CDCl3): δ -9.5 ppm. HRMS: Calcd (M+H+) 671.1009; Found 
671.1017. 
 
(2', 6'-Dimethoxy-[1,1'-biphenyl]-2-yl) di-o-tolylphosphine 
(L12). 
Using the procedure above, a white solid (373.2 mg, 0.88 mmol, 
43.8% yield) was obtained. 1H NMR (300MHz, CDCl3): δ 7.40 (t, 











ppm. 13C NMR (300 MHz, CDCl3): δ 158.1, 143.0, 142.6, 137.0, 134.2, 133.9, 131.2, 131.1, 
129.8, 129.7, 129.1, 128.8, 128.2, 127.4, 125.8, 103.4, 55.3, 21.4, 21.1 ppm. 31P NMR (121 





Using the procedure above, a white needle-like solid (220.2 mg, 
0.41 mmol, 20.6 % yield) was obtained. 1H NMR (300MHz, 
CDCl3): δ 7.53 (m, 4H), 7.46 (td, J1 = 7.3 Hz, J2 = 1.0 Hz, 1H), 
7.29 (m, 7H), 7.09 (ddd, J1 = 7.4 Hz, J2 = 3.6 Hz, J3 = 1.0 Hz, 1H), 6.53 (d, J = 8.3 Hz, 2H), 3.47 
(s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.9, 142.9, 142.7, 142.2, 141.7, 136.1, 136.0, 
134.0, 131.6, 131.5, 130.7, 130.3, 129.8, 129.7, 127.9, 126.1, 125.1, 125.1, 125.1, 125.0, 122.5, 




Preparation of diphenylXPhos derivatives 
 









3 mol %, 1,2-dibromoethane
1.0 equiv 1.1 equiv




1.05 equiv nBuLi (1.5 M, hexane)
0.4 M THF













Magnesium turnings (1.92 g, 80.0 mmol, 4.0 equiv) were added to a 100 mL 2-neck round 
bottom flask, which had been dried overnight in an oven. The flask was equipped with a 
condenser and rubber septum, and evacuated (ca. 200 mtorr) and backfilled with argon for 4 
times. Dry THF (28 mL) was injected via syringe. 2-Bromo-1,3,5-triisopropylbenzene (7.15 mL, 
20.0 mmol, 1.0 equiv) was injected into the mixture via syringe, the flask was heated to 70 ºC, 
and 1,2-dibromoethane (50 uL) was added via microsyringe. After 1 hour at reflux, 2- 
bromochlorobenzene (2.58 mL, 22 mmol, 1.1 equiv) was added dropwise via a syringe with a 
syringe pump over 0.5 h. And after additional 1 hour at reflux, the mixture was cooled down to 
room temperature and a solution of I2 (11.12 g, 44 mmol, in 20 mL THF, 2.2 equiv) was added 
via cannula until a deep purple color persisted. The reaction mixture was then quenched with 
methanol (10 mL), dissolved in ethyl acetate (200 mL), and filtered. The filtrate was washed 
successively with aqueous Na2S2O3 and brine, and dried over anhydrous Na2SO4. The solution 
was filtrated, and then concentrated under reduced pressure. A pale yellow crystalline solid (6.4 
g, 15.8 mmol, 79% yield) was obtained following recrystallization from methanol. 1H NMR (300 
MHz, CDCl3): δ 7.95 (dd, J1 = 7.9 Hz, J2 = 0.9 Hz, 1H), 7.38 (dt, J1 = 7.4 Hz, J2 = 1.1 Hz, 1H), 
7.20 (dd, J1 = 7.5 Hz, J2 = 1.6 Hz, 1H), 7.06 (s, 2H), 7.08-7.00 (m, 1H), 2.96 (septet, J = 6.9 Hz, 
1H), 2.40 (septet, J = 6.9 Hz, 2H), 1.32 (d, J = 6.9 Hz, 6H), 1.23 (d, J = 6.9 Hz, 6H), 1.02 (d, J = 
6.8 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 148.8, 146.1, 145.9, 139.4, 139.0, 130.7, 128.4, 
128.0, 121.0, 102.6, 34.4, 30.8, 25.1, 24.3, 23.7 ppm. 
 
Diaryl derivatives of (2',4',6'-triisopropyl-[1,1'-biphenyl]-2- 
yl)phosphine. 







equiv) was added into an oven-dried 25 mL round bottom flask. The flask was sealed with a 
rubber septum and evacuated (ca. 200 mtorr) and backfilled with argon for 4 times. THF (5 mL) 
was injected, and the flask was cooled in a -78 oC dry ice/acetone bath. n-BuLi (1.37 mL, 2.1 
mmol, 1.53 M, in hexane, 1.05 equiv) was injected via syringe dropwise over 15 min. The 
mixture was stirred at -78 ºC for 30 min. A pre-dissolved solution of diphenylphosphine chloride 
derivative (2.0 mmol, in 2 mL THF, 1.0 equiv) was injected via syringe over 15 min. The 
mixture was stirred at -78 ºC for 1 h, and then was warmed to rt and stirred for another 1.5 h. The 
crude mixture was quenched by methanol (0.5 mL) and dissolved by ethyl acetate (10 mL). The 
solution was filtrated through a pad of silica gel and washed with ethyl acetate (20 mL). The 
solvent was removed under reduced pressure, and an off-white crystalline solid was isolated 
following column chromatography.  
 
Bis(3,5-bis(trifluoromethyl)phenyl)(2',4',6'-triisopropyl-[1,1'-
biphenyl]-2-yl)phosphane (L14). [10b] 
Using the procedure above, a white solid (807.5 mg, 1.1 mmol, 
55% yield) was isolated following column chromatography (100 % 
hexane). 1H NMR (300 MHz, CDCl3): δ 7.86 (s, 1H), 7.57 (d, J = 
6.0 Hz, 4H), 7.54 (d, J = 8.0 Hz, 1H), 7.49-7.40 (m, 1H), 7.37-7.29 (m, 1H), 7.19-7.11 (m, 1H), 
7.00 (s, 2H), 2.95 (septet, J = 6.9 Hz, 1H), 2.27 (septet, J = 6.8 Hz, 2H), 1.30 (d, J = 6.9 Hz, 6H), 
1.00 (d, J = 6.7 Hz, 6H), 0.82 (d, J = 6.9 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 149.2, 
148.9, 148.4, (146.4, 146.4) 140.6, 140.3, 135.0, 134.9, (134.7, 134.6), 133.2, 132.9, 132.9, 
132.5, 132.4, 132.1, 132.0, 131.9, 131.8, 131.6, 131.5, 130.8, 128.4, 124.9 (quintet), 123.1, 












Using the procedure above, a white solid (270 mg, 0.45 mmol, 
45% yield) was isolated following column chromatography 
(100% hexane). 1H NMR (300 MHz, CD2Cl2): δ 7.56 (d, J = 7.9 
Hz, 4H), 7.51-7.44 (m, 1H), 7.37 (dt, J1 = 7.53 Hz, J2 = 1.4 Hz, 1H), 7.29 (t, J = 6.8 Hz, 4H), 
7.26-7.16 (m, 2H), 7.00 (s, 2H), 2.93 (septet, J = 6.9 Hz, 1H), 2.32 (septet, J = 6.8 Hz, 2H), 1.29 
(d, J = 6.9 Hz, 6H), 0.96 (d, J = 6.8 Hz, 6H), 0.80 (d, J = 6.9 Hz, 6H) ppm. 13C NMR (300 MHz, 
CDCl3): δ 148.7, 148.5, 148.0, 146.5, 146.5, 142.5, 142.3, 135.6, 135.5, 135.3, 135.2, 134.0, 
133.7, 131.5, 131.4, 131.0, 130.6, 129.8, 127.7, 126.0, 125.5, 125.5, 125.4, 125.4, 125.4, 122.4, 
120.7, 34.4, 31.0, 25.7, 24.2, 22.4, 22.4 ppm. 31P NMR (121 MHz, CDCl3): δ -17.7 ppm. HRMS: 
Calcd (M+H+) 601.2459; Found 601.2454. 
 
Preparation of mono-ligated 3rd and 4th generation Buchwald’s palladium catalyst precursor[11] 
 
Procedure A (for air-sensitive ligands): [11a]
 
On the bench top, Buchwald’s 3rd generation 
palladium dimer (738 mg, 1.0 mmol, 0.5 equiv) was added into an oven-dried 50 mL round 




















selected ligand (2.0 mmol, 1.0 equiv) was added. Freshly distilled THF (12 mL) was added into 
the mixture via syringe outside glovebox. The mixture was stirred under room temperature for 2 
to 12 h, until the solid was dissolved. A gravity filtration is required if black Pd(0) particles 
precipitate. The filtrate was collected and concentrated via rotary evaporator. The solid catalyst 
precursor was obtained via recrystallization in ether/hexane. The yellow/brown solid was washed 




On a bench top, Buchwald’s 3rd
 
generation palladium dimer (240 mg, 0.32 
mmol, 0.65 equiv), and ligand (0.5 mmol, 1.0 equiv) was added to a 25 mL oven- dried round 
bottom flask, which was equipped with a stirbar. The flask was sealed with a rubber septum and 
evacuated (ca. 200 mtorr) and back filled with argon 3 times. 8.0 mL freshly distilled 
dichloromethane was injected into the mixture via syringe. The mixture was stirred at room 
temperature for 2 h. Diethyl ether (10 mL) was added into the mixture, which was filtered 
through a tightly packed cotton plug. The cotton plug was washed with diethyl ether (10 mL x 2). 
The filtrates were combined, concentrated under reduced pressure, and recrystallized from 
ether/hexane. A pale-yellow solid was collected on a fritted funnel, washed with hexane (10 mL 
x 3) and dried under vacuum for 24 h.  
 
Procedure C: [11b,c] On the benchtop, Buchwald’s 4th
 
generation (N-methyl) palladium dimer 
(104.6 mg, 0.14 mmol, 0.65 equiv), and ligand (0.21 mmol, 1.0 equiv) were added to a 25 mL 
oven-dried round bottom flask, which was equipped with a stirbar. The flask was sealed with 
septum, and evacuated (ca. 200 mtorr) and back filled with argon 3 times. Dichloromethane (3.5 
mL) was injected into the mixture via syringe. The mixture was stirred at room temperature for 2 
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h. The solvent (DCM) was removed under reduced pressure. The remaining residue was re-
dissolved in diethyl ether (10 mL), and insoluble particles was filtered using a cotton plug, which 
was then washed with ether (5 mL x 2). The combined filtrates were concentrated under reduced 
pressure and thoroughly dried under vacuum.  
 
 
Tri(1-adamantyl)phosphine [12]-ligated 3rd Buchwald’s 
palladium catalyst precursor (G3-Pd-PAd3).  
Follow Procedure A, a golden yellow powder was acquired 
(1.54 g, 1.90 mmol, 95 % yield). Note that yellow solid may 
precipitate, if stirring overnight, and cannot be dissolved by excessive THF. 5 mL 
dichloromethane was added to dissolve the solid (in 0.5 mmol scale reaction). Insoluble solid 
was filtrated through cotton plug. The filtrates was condensed by rotary evaporator till little 
liquid left. Yellow solid was obtained by the addition of hexane.  1H NMR (300 MHz, CDCl3): δ 
7.73-7.52 (br, 1H), 7.50-7.42 (m, 2H), 7.40 (d, J = 7.5 Hz, 1H), 7.31-7.22 (m, 1H), 7.22-7.11 (m, 
2H), 7.10-6.95 (m, 2H), 3.98 (br, 1H), 2.80 (s, 3H), 2.26 (s, 18H), 1.89 (s, 9H), 1.62 (m, 18H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 141.3, 140.1, 139.3, 138.6(d), 137.5, 128.7, 127.1, 126.5, 
126.1, 125.7, 124.7, 119.7, 48.7, 48.7, 41.5, 40.3, 36.6, 29.5, 29.4 ppm. 31P NMR (121 MHz, 
CDCl3): δ 61.21 ppm. 
 
CataCXium® A-ligated 3rd Buchwald’s palladium catalyst 
precursor (G3-Pd-nBuPAd2): 









L L = nBuPAd2
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yield from 0.8 mmol starting reactant) was acquired. 1H NMR (300 MHz, CDCl3): δ 7.49-7.35 
(m, 3H), 7.25-7.10 (m, 3H), 7.10-6.93 (m, 2H), 4.16 (br, 1H), 2.82 (s, 3H), 2.30-2.11 (m, 6H), 
2.11-1.94 (m, 9H), 1.90-1.69 (m, 9H), 1.68-1.54 (m, 6H), 1.48-1.32 (m, 1H), 1.16-0.99 (m, 1H), 
1.00-0.79 (m, 2H), 0.64-0.45 (m, 4H), 0.41-0.21 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 
146.2, 140.4, 137.7(d), 136.8, 136.8, 128.3, 127.8, 127.8, 127.1, 125.5, 125.5, 124.8, 120.1, 41.6, 
41.4, 40.8, 40.6, 40.3, 40.1, 36.9, 36.7, 29.1, 29.0, 28.9, 28.8, 28.8, 27.9, 25.6, 25.5, 17.9, 17.7, 




ligated 3rd generation Buchwald’s catalyst 
precursor. 
Follow Procedure B, a pale yellow solid 
(430.0 mg, 0.42 mmol, 84% yield from 0.5 
mmol starting reactant) was acquired. 1H NMR (300 MHz, CDCl3): δ 9.40-9.20 (br, 1H), 7.84 (t, 
J=7.3, 1H), 7.74 (t, J=5.8 Hz, 2H), 7.62 (s, 1H), 7.58-7.39 (m, 4H), 7.38-7.30 (m, 2H), 7.26-7.11 
(m, 4H), 7.05 (t, J=5.2 Hz, 1H), 6.60 (s, 3H), 6.42 (s, 1H), 4.72-4.56 (br, 1H), 2.66 (septet, J=6.7 
Hz, 1H), 2.30(s, 3H), 2.17 (septet, J=7.2 Hz, 2H), 1.06 (d, J=4.5 Hz, 6H), 0.80 (d, J=5.7 Hz, 
6H), 0.48 (d, J=5.8 Hz, 3H), 0.31 (d, J=6.4 Hz, 3H) ppm. 13C NMR (75 MHz): 149.4, 145.8, 
145.4, 145.2, 140.2, 139.8, 139.3, 138.4, 137.1, 136.9, 135.9, 135.3, 134.6, 133.8, 133.1, 132.3, 
131.5, 131.3, 131.0, 130.4, 128.8, 128.3, 128.1, 127.9, 127.9, 127.8, 127.6, 126.5, 126.2, 124.9, 
124.5, 124.4, 123.8, 123.2, 121.4, 120.9, 120.7, 120.6, 39.0, 33.4, 30.6, 25.8, 25.5, 23.6, 23.1, 















ligated 4th generation Buchwald’s catalyst 
precursor. 
Follow Procedure C, a yellow solid (147.9 
mg, 63 % yield) was obtained. 1H NMR 
(300 MHz, CDCl3): δ 9.29 (d, J = 12.0 Hz, 1H), 7.87 (t, J = 7.2 Hz, 1H), 7.73 (s, 2H), 7.68-7.40 
(m, 5H), 7.40-6.94 (m, 8H), 6.60 (s, 3H), 6.43 (s, 1H), 2.66 (septet, J = 6.8 Hz, 1H), 2.58 (q, J = 
2.0 Hz, 3H), 2.28 (s, 3H), 2.16 (septet, J = 6.4 Hz, 3H), 1.05 (dd, J1 = 6.5 Hz, J2 = 4.4 Hz, 6H), 
0.80 (t, J = 5.0 Hz, 6H), 0.48 (d, J = 6.5 Hz, 3H), 0.30 (d, J = 6.6 Hz, 3H) ppm. 13C NMR (75 
MHz, CDCl3): δ 149.4, 145.8, 145.4, 145.1, 141.6, 141.5, 140.6, 140.2, 139.8, 138.2, 136.5, 
136.4, 136.0, 135.9, 135.5 (br), 134.8 (br), 133.8, 133.8, 132.2, 132.2, 131.8 (q), 131.4, 131.4, 
131.3, 131.2, 131.0, 130.9, 130.8, 130.8,129.0, 128.6, 128.3, 128.1, 127.7, 127.6, 127.2, 126.3, 
124.8 (br), 124.6, 124.4, 124.2 (br), 123.8, 123.3, 121.7, 121.6, 121.4, 120.9, 120.7, 120.6, 40.8, 
40.8, 38.9, 33.4, 30.6, 30.5, 25.8, 25.5, 23.6, 23.1, 21.5, 21.4 ppm. 31P NMR (121 MHz, CDCl3): 
δ 44.31 ppm. 
	
Di(3,5-di-trifluoromethyl)phenyl SPhos-
ligated 3rd generation Buchwald’s catalyst 
precursor. 
Follow Procedure B, a pale yellow solid 






















MHz, CDCl3): δ 8.24 (dd, J1 = 16.7, J2 = 7.6 Hz, 1H), 7.75 (s, 1H), 7.72-7.58 (m, 4H), 7.57-
7.7.29 (m, 7H), 7.26-7.18 (m, 2H), 7.18-7.11 (m, 1H), 7.05 (t, J = 6.4 Hz, 1H), 6.86 (t, J = 8.4 
Hz, 1H), 6.71-6.45 (m, 2H), 6.12 (d, J = 7.2 Hz, 1H), 5.97 (d, J = 7.0 Hz, 1H), 4.55 (br, 1H), 
3.46 (s, 3H), 3.32 (s, 3H), 2.34 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.3, 141.6, 140.7, 
140.7, 139.6, 138.1, 138.0, 137.8, 137.6, 137.2, 135.3, 135.3, 134.8, 134.6, 134.4, 134.4, 132.4, 
131.0, 130.6, 128.6, 127.9, 127.9, 127.8, 127.7, 127.7, 127.4, 126.3, 126.1, 124.8, 124.7, 124.0, 
121.0, 116.7, 116.7, 103.6, 55.2, 39.2 ppm. 31P NMR (121 MHz, CDCl3): δ 36.74 ppm. 
 
Procedure for Suzuki Cross-Coupling Reaction 
General procedure 1 (Table 2-2, Table 2-3) 
On the benchtop, the aryl chloride (0.50 mmol), alkyl boronic acid or trifluoroborate (0.75 
mmol), K2CO3 (207 mg, 1.5 mmol), and 3rd generation t-Bu3P Buchwald precatalyst
 
(0.025 
mmol) were added to an oven-dried 10 mL screw-top test tube equipped with a stirbar. The test 
tube was sealed with a screw-top septum and electrical tape. The reaction vessel was evacuated 
(ca. 200 mtorr) and backfilled with argon four times. If the aryl chloride were a liquid, it was 
added to the reaction vessel via syringe at this point. Toluene (1.0 mL) and degassed water (0.5 
mL) were then added via syringe. The septum was covered with electrical tape, and the reaction 
vessel was heated to 100 ºC for 24 h. The cooled reaction mixture was transferred to a separatory 
funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl acetate (3 x 10 
mL). The combined organic layers were washed with brine (10 mL) and dried over Na2SO4. The 




General procedure 2 (Table 2-3) 
On the benchtop, the aryl chloride (0.50 mmol), alkyl trifluoroborate (0.75 mmol), K2CO3 (207 
mg, 1.5 mmol), and third generation t-Bu3P Buchwald precatalyst
 
(0.05 mmol) were added to an 
oven-dried Schlenk tube equipped with a stirbar. The Schlenk tube was capped with a rubber 
septum and evacuated (ca. 50 mTorr) and backfilled five times with argon through the side arm 
of the Schlenk flask. If the aryl chloride were a liquid, it was added to the reaction vessel via 
syringe at this point. Benzene (1.0 mL) or toluene (1.0 mL) and degassed water (1.0 mL for 
benzene, 0.5 mL for toluene) were then added via syringe. Under a flow of argon, the rubber 
septum was replaced with a Teflon stopper and the Schlenk tube was sealed. The reaction vessel 
was heated to 60 ºC for 48 h in an oil bath. The cooled reaction mixture was transferred to a 
separatory funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl 
acetate (3 x 10 mL). The combined organic layers were washed with brine (10 mL) and dried 
over Na2SO4. The organic layer was filtered, concentrated under reduced pressure, and purified 
by column chromatography on silica gel.  
 
General procedure 3 (conditions A1, table 4-1)  
On the bench top, Cs2CO3 (293.2 mg, 0.9 mmol), di(3,5-di-trifluoromethyl)phenyl-SPhos (11)-
ligated 3rd
 
generation Buchwald’s catalyst precursor (9.4 mg, 9.0 µmol), additional 11 (6.0 mg, 
9.0 µmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide (if solid) (0.3 mmol) were added 
to an oven-dried 16 mL screw-top glass culture tube equipped with a stirbar. Then the test tube 
was sealed with a screw-top septum and electrical tape. Using a needle attached to a vacuum 
manifold, the reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon for 3 
times. Toluene (0.6 mL) and degassed water (0.6 mL) were then added via syringe. If the aryl 
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halide were a liquid, it was added to the vessel via syringe at this point. Then the septum was 
covered with electrical tape, and the vessel was heated to the specified temperature for 24-48 h. 
Following reaction, the contents of the cooled reaction mixture was transferred to a separatory 
funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl acetate (3 x 10 
mL). The combined organic layers were washed with brine (10 mL) and dried over Na2SO4. The 
organic layer was filtered, concentrated under reduced pressure, and additionally purified by 
column chromatography.  
 
General procedure 4 (conditions A2, table 4-1)  
On the bench top, K2CO3 (124.2 mg, 0.9 mmol), di(3,5-di-trifluoromethyl)phenyl XPhos (14)-
ligated 3rd
 
generation Buchwald’s catalyst precursor (9.9 mg, 9.0 µmol), additional 14 (6.6 mg, 
9.0 µmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide (if solid) (0.3 mmol) were added 
to an oven-dried 16 mL screw-top glass cultural tube equipped with a stirbar. The test tube was 
sealed with a screw-top septum and electrical tape. Using a needle attached to a vacuum 
manifold, the reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times. 
Toluene (0.6 mL) and degassed water (0.6 mL) were then added via syringe. If the aryl halide 
were a liquid, it was added to the vessel via syringe at this point. Then the septum was covered 
with electrical tape, and the vessel was heated to the specified temperature for 24-48 h. 
Following reaction, contents of the cooled reaction mixture was transferred to a separatory 
funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl acetate (3 x 10 
mL). The combined organic layers were washed with brine (10 mL) and dried over Na2SO4. The 




General procedure 5 (conditions B, table 4-1):  
On the bench top, K2CO3 (124.2 mg, 0.9 mmol), PAd3(9)-ligated 3rd
 
generation Buchwald’s 
precursor (12 mg, 0.015 mmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide (if solid) 
(0.3 mmol) were added to an oven-dried 16 mL screw-top glass culture tube equipped with a 
stirbar. The test tube was sealed with a screw-top septum and electrical tape. Using a needle 
attached to a vacuum manifold, the reaction vessel was evacuated (ca. 100 mtorr) and backfilled 
with argon 3 times. Toluene (0.6 mL) and degassed water (0.3 mL) were then added via syringe. 
If the aryl halide were a liquid, it was added to the vessel via syringe at this point. Then the 
septum was covered with electrical tape, and the vessel was heated to the specified temperature 
(60-100 ºC) for 24 h. Following completion of the reaction, the cooled reaction mixture was 
transferred to a separatory funnel, diluted with saturated NH4Cl solution (10 mL), and extracted 
with ethyl acetate (3 x 10 mL). The combined organic layers were washed with brine (10 mL) 
and dried over Na2SO4. The organic layer was filtered, concentrated under reduced pressure, and 




(6a). General procedure 1 was 
employed using 4-chloroanisole (71 mg, 0.5 mmol) and iso-
propylboronic acid (66 mg, 0.75 mmol). A colorless liquid (run 1: 57 mg, 
76%; run 2: 62 mg, 82%) was isolated by column chromatography (99.5:0.5 Hex/ether). 1H 
NMR (500 MHz, CDCl3): δ 7.16 (d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.3 Hz, 2H), 3.80 (s, 3H), 2.87 
(septet, J = 7.0 Hz, 1H), 1.23 (d, J = 7.0 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 157.8, 






(6a’). General procedure 1 was employed using 4-chloroanisole (71 mg, 0.5 mmol) and 
potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A colorless liquid (run 1: 61 mg, 81%; 
run 2: 63 mg, 84%) was isolated by column chromatography (99.5:0.5 Hex/ether).  
 
1-(sec-Butyl)-4-methoxybenzene[13] (7a). General procedure 1 was 
employed using 4-chloroanisole (71 mg, 0.5 mmol) and sec-butylboronic 
acid (77 mg, 0.75 mmol). A colorless liquid (run 1: 68 mg, 83%: run 2: 
51 mg, 62%) was isolated by column chromatography (98:2 Hex/ether). 1H NMR (500 MHz, 
CDCl3): δ 7.10 (d, J = 8.6, 2H), 6.84 (d, J = 8.7 Hz, 2H), 3.79 (s, 3H), 2.55 (m, 1H), 1.56 (m, 
2H), 1.21 (d, J = 7.0 Hz, 3H), 0.81 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 
157.8, 139.9, 128.0, 113.7, 55.4, 41.0, 31.5, 22.3, 12.5 ppm.  
(7a’). General procedure 1 was employed using 4-chloroanisole (71 mg, 0.5 mmol) and 
potassium (R)-sec-butyltrifluoroborate (123 mg, 0.75 mmol). A colorless liquid (run 1: 65 mg, 
79%; run 2: 76 mg, 92%) was isolated by column chromatography (98:2 Hex/ether). (Figure 3, 
row 1, column 3). General procedure 1 was employed at 60 ºC using (R)-sec-
butyltrifluoroborate. Optical rotation of product: [α]20D (c 1.00, CHCl3) = +18.6º.  
 
(R)-1-(sec-butyl)-4-methoxybenzene (Table 4-1, (R)-23a)  
General procedure 4 was employed with 4-methoxyphenyl 
trifluoromethanesulfonate (55.8 µL, 0.3 mmol, 1.0 equiv), potassium (R)-
sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv), cesium carbonate (293.2 mg, 0.9 
mmol, 3.0 equiv) was used alongside 4th
 








and additional ligand (22.0 mg, 0.03 mmol, 10 mol %). The reaction mixture was heated to 100 
ºC and stirred for 48 h. A colorless liquid (31.2 mg, 50% yield) was isolated following column 
chromatography (99:1 hexane/ether). Enantiopurity of the product was determined by chiral GC 
(89% ee). A duplicate run on 0.05 mmol scale afforded the product with 89% ee. 1H NMR (300 
MHz, CDCl3): δ 7.13-7.06 (m, 2H), 6.87-6.81 (m, 2H), 3.79 (s, 3H), 2.55 (sextet, J = 7.0 Hz, 
1H), 1.56 (quintet, J = 7.3 Hz, 2H), 1.21 (d, J = 6.9 Hz, 3H), 0.81 (t, J = 7.3 Hz, 3H) ppm. 13C 
NMR (75 MHz, CDCl3): δ 157.9, 140.0, 128.0, 113.8, 55.4, 41.0, 31.5, 22.2, 12.4 ppm. Optical 
rotation of this product [α]25D (c 1.00, CHCl3) = -20.6 º.  
 
(S)-1-(sec-butyl)-4-methoxybenzene (Table 4-1, (S)-23a).  
General procedure B was employed with 4-chloroanisole (36.7 µL, 0.3 
mmol, 1.0 equiv) and potassium (R)-sec-butyltrifluoroborate (73.6 mg, 
0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was heated to 80 ºC and stirred for 24h. A 
colorless liquid (run 1 (racemic): 42.4 mg, 86%; run 2 (enantioenriched): 40.1 mg, 82%, 98% ee) 
was obtained following column chromatography (98:2 hexane/ether). A duplicate run of the 
enantioenriched variant on 0.05 mmol scale afforded the product with 96% ee. 1H NMR (300 
MHz, CDCl3): δ 7.13- 7.06 (m, 2H), 6.87-6.81 (m, 2H), 3.79 (s, 3H), 2.55 (sextet, J = 7.0 Hz, 
1H), 1.56 (quintet, J = 7.3 Hz, 2H), 1.21 (d, J = 6.9 Hz, 3H), 0.81 (t, J = 7.3 Hz, 3H) ppm. 13C 
NMR (75 MHz, CDCl3): δ 157.9, 140.0, 128.0, 113.8, 55.4, 41.0, 31.5, 22.2, 12.4 ppm. Optical 




(6b). General procedure 1 was 








propylboronic acid (66 mg, 0.75 mmol). An oily, yellow liquid (run 1: 72 mg, 87%; run 2: 63 
mg, 76%) was isolated by column chromatography (99:1 Hex/ether). 1H NMR (500 MHz, 
CDCl3): δ 8.15 (d, J = 8.5 Hz, 2H), 7.37 (d, J = 8.6 Hz, 2H), 3.02 (septet, J = 6.8 Hz, 1H), 1.29 
(d, J = 6.9 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 256.8, 146.3, 127.4, 123.8, 34.4, 23.8 
ppm.  
 
(6b’). General procedure 1 was employed using 1-chloro-4-nitrobenzene (79 mg, 0.5 mmol) and 
potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). An oily, yellow liquid (run 1: 60 mg, 
73%; run 2: 50 mg, 61%) was isolated by column chromatography (99:1 Hex/ether).  
 
 1-(sec-Butyl)-4-nitrobenzene[15] (7b). General procedure 1 was 
employed using 1-chloro-4-nitrobenzene (79 mg, 0.5 mmol) and sec-
butylboronic acid (77 mg, 0.75 mmol). An oily, yellow liquid (run 1: 70 
mg, 78%; run 2: 62 mg, 69%) was isolated by column chromatography (99:1 Hex/ether). 1H 
NMR (500 MHz, CDCl3): δ 8.15 (d, J = 8.7 Hz, 2H), 7.33 (d, J = 8.6 Hz, 2H), 2.73 (m, 1H), 1.63 
(m, 2H), 1.27 (d, J = 6.9 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 
155.7, 146.4, 128.0, 123.8, 41.9, 31.0, 21.7, 12.3 ppm.  
 
(7b’). General procedure 1 was employed using 1-chloro-4-nitrobenzene (79 mg, 0.5 mmol) and 
potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). An oily, yellow liquid (run 1: 64 mg, 












employed using 3-chloroanisole (71 mg, 0.5 mmol) and iso-propylboronic acid (66 mg, 0.75 
mmol). A colorless liquid (run 1: 62 mg, 83%; run 2: 62 mg, 83%) was isolated by column 
chromatography (99:1 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.23 (t, J = 7.8 Hz, 1H), 6.84 
(d, J = 7.5 Hz, 1H), 6.79 (m, 1H), 6.73 (d, J = 7.8 Hz, 1H), 3.82 (s, 3H), 2.89 (septet, J = 6.8 Hz, 
1H), 1.26 (d, J = 6.8 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 159.7, 150.8, 129.4, 119.1, 
112.6, 110.8, 55.3, 34.4, 24.2 ppm.  
 
(6c’). General procedure 1 was employed using 3-chloroanisole (71 mg, 0.5 mmol) and 
potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A colorless liquid (run 1: 61 mg, 82%; 





General procedure 1 was employed using 3-chloroanisole (71 mg, 0.5 
mmol) and sec-butylboronic acid (77 mg, 0.75 mmol). A colorless liquid 
(run 1: 62 mg, 75%; run 2: 72 mg, 87%) was isolated by column chromatography (99:1 
Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.21 (t, J = 7.6 Hz, 1H), 6.79 (d, J = 7.7 Hz, 1H), 
6.74 (s, 1H), 6.73 (m, 1H), 3.81 (s, 3H), 2.57 (app. sextet, J = 7.0 Hz, 1H), 1.59 (m, 2H), 1.23 (d, 
J = 6.9 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 159.7, 149.6, 
129.3, 119.7, 113.2, 110.8, 55.3, 42.0, 31.3, 22.1, 12.5 ppm.  
 
(7c’). General procedure 1 was employed using 3-chloroanisole (71 mg, 0.5 mmol) and 
potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A colorless liquid (run 1: 70 mg, 85%; 






 (R)-1-(sec-butyl)-3-methoxybenzene (Table 4-1, (R)-23e).  
General procedure 4 was employed with 3-bromoanisole (38.1 µL, 0.3 
mmol, 1.0 equiv) and potassium (R)- sec-butyltrifluoroborate (73.6 mg, 
0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was heated to 100 ºC and stirred for 30 h. A 
colorless liquid (32.5 mg, 66% yield, 93% ee) was isolated following column chromatography 
(98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded 
the product with 93% ee. 1H NMR (300 MHz, CDCl3): δ 7.23-7.18 (m, 1H), 6.81-6.69 (m, 3H), 
3.80 (s, 3H), 2.57 (sextet, J = 7.1 Hz, 1H), 1.58 (m, 2H), 1.23 (d, J = 7.0 Hz, 3H), 0.82 (t, J = 7.4 
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 159.8, 149.7, 129.3, 119.7, 113.2, 110.9, 55.3, 42.0, 
31.3, 22.0, 12.4 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -18.0 º.  
 
(S)-1-(sec-butyl)-3-methoxybenzene (Table 4-1, (S)-23e). 
General procedure B was employed with 3-chloroanisole (36.6 µL, 0.3 
mmol, 1.0 equiv) and potassium (R)- sec-butyltrifluoroborate (73.6 mg, 
0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was heated to 80 ºC and stirred for 24 h. A 
colorless liquid (40.2 mg, 82% yield, 95% ee) was isolated following column chromatography 
(98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded 
the product with 95% ee. 1H NMR (300 MHz, CDCl3): δ 7.23-7.18 (m, 1H), 6.81-6.76 (m, 1H), 
6.74 (d, J = 1.3 Hz, 1H), 6.75-6.69 (m, 1H), 3.80 (s, 3H), 2.57 (sextet, J = 7.1 Hz, 1H), 1.58 (dq, 
J1 = 7.5 Hz, J2 = 1.1 Hz, 2H), 1.23(d, J = 7.0 Hz, 3H), 0.82 (t, J = 7.4 Hz, 3H) ppm. 13C NMR 
(75 MHz, CDCl3): δ 159.8, 149.7, 129.3, 119.7, 113.2, 110.9, 55.3, 42.0, 31.3, 22.0, 12.4 ppm. 









1-(4-(iso-Propyl)phenyl)-1H-pyrrole (Table 2, 6d).  
General procedure 1 was employed using 1-(4-chlorophenyl)-1H-
pyrrole (89 mg, 0.5 mmol) and iso-propylboronic acid (66 mg, 0.75 
mmol). A brownish liquid (81 mg, 88%) was isolated by column chromatography (99.5:0.5 
Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.32 (d, J = 8.5 Hz, 2H), 7.28 (d, J = 8.5 Hz, 2H), 
7.06 (t, J = 2.1 Hz, 2H), 6.33 (t, J = 2.1 Hz, 2H), 2.94 (septet, J = 6.9 Hz, 1H), 1.27 (d, J = 6.9 
Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 146.5, 138.9, 127.6, 120.8, 119.5, 110.2, 33.8, 
24.2 ppm. HRMS (FAB): Calcd (M+H+) 186.1283; Found 186.1275.  
 
(Table 2, 6d’). General procedure 1 was employed using 1-(4-chlorophenyl)-1H- pyrrole (89 mg, 
0.5 mmol) and potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A brownish liquid (run 
1: 54 mg, 58%; run 2: 75 mg, 81%; run 3: 77 mg, 83%) was isolated by column chromatography 




(Table 2, 7d). General 
procedure 1 was employed using 1-(4-chlorophenyl)-1H-pyrrole (89 
mg, 0.5 mmol) and sec-butylboronic acid (77 mg, 0.75 mmol). A 
brownish liquid (84 mg, 84%) was isolated by column chromatography (99.4:0.6 Hex/ether). 1H 
NMR (500 MHz, CDCl3): δ 7.32 (d, J = 8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 7.08 (t, J = 2.1 
Hz, 2H), 6.34 (t, J = 2.1 Hz, 2H), 2.64 (m, 1H), 1.62 (m, 2H), 1.26 (d, J = 6.9 Hz, 3H), 0.85 (t, J 
= 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 145.4, 138.9, 128.2, 120.8, 119.6, 110.2, 









(Table 2, 7d’). General procedure 1 was employed using 1-(4-chlorophenyl)-1H- pyrrole (89 mg, 
0.5 mmol) and potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A brownish liquid (run 
1: 53 mg, 53%; run 2: 83 mg, 83%; run 3: 79 mg, 79%) was isolated by column chromatography 
(99.4:0.6 Hex/ether). General procedure 1 was employed using (R)-sec-butyltrifluoroborate. 
Optical rotation of product: [α]20D (c 1.00, CHCl3) = +17.1º.  
 
(R)-1-(4-(sec-butyl) phenyl)-1H-pyrrole (Table 4-1, (R)- 23g). 
General procedure 4 was employed with 1-(4- chlorophenyl)-1H-
pyrrole (53.3 mg, 0.3 mmol, 1.0 equiv), potassium (R)-sec-
butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee), precatalyst (16.6 mg, 0.015 mmol, 
5 mol %) and additional ligand (11.0 mg, 0.015mmol, 5 mol %). The reaction mixture was 
heated to 110 ºC for 24 h. A colorless liquid (31.2 mg, 52% yield, 85% ee) was isolated 
following column chromatography (100% hexane). A duplicate run of the enantioenriched 
variant on 0.05 mmol scale afforded the product with 85% ee. 1H NMR (300 MHz, CDCl3): δ 
7.34-7.28 (m, 2H), 7.24-7.19 (m, 2H), 7.06 (t, J = 2.2 Hz, 2H), 6.32 (t, J = 2.2 Hz, 2H), 2.63 
(sextet, J= 7.0 Hz, 1H), 1.61 (quintet, J= 7.3 Hz, 2H), 1.26 (d, J= 7.0 Hz, 3H), 0.84 (t, J= 7.4 Hz, 
3H) ppm. 13C NMR (75 MHz, CDCl3): δ 145.4, 138.9, 128.2, 120.7, 119.6, 110.2, 41.3, 31.4, 
22.0, 12.4 ppm. Optical rotation of this product [α]25D(c 1.00, CHCl3) = -21.6 º.  
 
 (S)-1-(4-(sec-butyl) phenyl)-1H-pyrrole (Table 4-1, (S)- 23g). 
General procedure 5 was employed with 1-(4-chlorophenyl)-1H- 








butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was heated 
to 80 ºC for 48 h. A colorless liquid (38.5 mg, 64% yield, 95% ee) was isolated following column 
chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol 
scale afforded the product with 95% ee. 1H NMR (300 MHz, CDCl3): δ 7.34-7.28 (m, 2H), 7.24-
7.19 (m, 2H), 7.06 (t, J = 2.2 Hz, 2H), 6.32 (t, J = 2.2 Hz, 2H), 2.63 (hex, J = 7.0 Hz, 1H), 1.61 
(quintet, J = 7.3 Hz, 2H), 1.26 (d, J = 7.0 Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 
MHz, CDCl3): δ 145.4, 138.9, 128.2, 120.7, 119.6, 110.2, 41.3, 31.4, 22.0, 12.4 ppm. Optical 




(Table 2, 6e).  
General procedure 1 was employed using 1-chloro-2,4-dimethylbenzene (67 
µL, 0.5 mmol) and iso-propylboronic acid (66 mg, 0.75 mmol). A colorless 
liquid (run 1: 62 mg, 84%; run 2: 54 mg, 72%) was isolated by column 
chromatography (99.8:0.2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.13 (d, J=7.9 Hz, 1H), 
7.02-6.93 (m, 2H), 3.10 (septet, J=6.8 Hz, 1H), 2.30 (s, 3H), 2.28 (s, 3H), 1.21 (d, J=6.9 Hz, 6H) 
ppm. 13C NMR (125 MHz, CDCl3): δ 144.0, 135.06, 135.05, 131.2, 127.0, 124.8, 29.1, 23.5, 
21.1, 19.5 ppm.  
 
(Table 2, 6e’). General procedure 1 was employed using 1-chloro-2,4- dimethylbenzene (67 µL, 
0.5 mmol) and potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A colorless liquid (run 









(Table 2, 7e).  
General procedure 1 was employed using 1-chloro-2,4-dimethylbenzene 
(67 µL, 0.5 mmol) and sec-butylboronic acid (77 mg, 0.75 mmol). A 
colorless liquid (run 1: 70 mg, 86%; run 2: 76 mg, 94%) was isolated by column chromatography 
(99.8:0.2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.08 (d, J = 7.9 Hz, 1H), 7.00 (d, J = 7.9 
Hz, 1H), 6.97 (s, 1H), 2.84 (m, 1H), 2.29 (s, 6H), 1.58 (m, 2H), 1.18 (d, J = 6.9 Hz, 3H), 0.86 (t, 
J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 143.0, 135.5, 134.9, 131.1, 127.0, 125.3, 
36.0, 30.8, 21.5, 21.1, 19.7, 12.6 ppm.  
 
(Table 2, 7e’). General procedure 1 was employed using 1-chloro-2,4- dimethylbenzene (67 µL, 
0.5 mmol) and potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A colorless liquid (run 
1: 76 mg, 93%; run 2: 71 mg, 88%) was isolated by column chromatography (99.8:0.2 
Hex/ether).  
 
5-(iso-Propyl)-3-methyl-1-benzothiophene (Table 2, 6f).  
General procedure 1 was employed using 5-chloro-3-methyl-1-
benzothiophene (91 mg, 0.5 mmol) and iso- propylboronic acid (66 mg, 
0.75 mmol). A colorless liquid (run 1: 86 mg, 90%; run 2: 88 mg, 92%) was isolated by column 
chromatography (99.8:0.2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 1H), 
7.55 (s, 1H), 7.26 (dd, J = 8.2, 1.2 Hz, 1H), 7.05 (s, 1H), 3.07 (septet, J = 6.9 Hz, 1H), 2.45 (s, 
3H), 1.34 (d, J = 6.9 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 145.0, 140.0, 137.9, 132.1, 











(Table 2, 6f’): General procedure 1 was employed using 5-chloro-3-methyl-1- benzothiophene 
(91 mg, 0.5 mmol) and potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A colorless 
liquid (run 1: 93 mg, 98%; run 2: 95 mg, 99%) was isolated by column chromatography 
(99.8:0.2 Hex/ether).  
 
5-(sec-Butyl)-3-methyl-1-benzothiophene (Table 2, 7f). General 
procedure 1 was employed using 5-chloro-3-methyl-1-benzothiophene 
(91 mg, 0.5 mmol) and sec- butylboronic acid (77 mg, 0.75 mmol). A 
colorless liquid (run 1: 92 mg, 90%; run 2: 91 mg, 89%) was isolated by column chromatography 
(99.8:0.2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.2 Hz, 1H), 7.50 (s, 1H), 7.21 
(dd, J = 8.3, 1.5 Hz, 1H), 7.05 (s, 1H), 2.74 (m, 1H), 2.44 (s, 3H), 1.68 (m, 2H), 1.32 (d, J = 6.9 
Hz, 3H), 0.85 (d, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 143.8, 140.0, 138.0, 
132.1, 123.9, 122.7, 121.7, 120.0, 42.1, 31.7, 22.6, 14.2, 12.6 ppm. HRMS (FAB+): Calcd (M+) 
204.0973; Found 204.0982.  
 
(Table 2, 7f’). General procedure 1 was employed using 5-chloro-3-methyl-1- benzothiophene 
(91 mg, 0.5 mmol) and potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A colorless 
liquid (run 1: 96 mg, 94%, run 2: 101 mg, 99%) was isolated by column chromatography 
(99.8:0.2 Hex/ether). (Figure, (S)-7f’). General procedure 1 was employed using (R)-sec-
butyltrifluoroborate. Optical rotation of product: [α]20D (c 1.00, CHCl3) = +24.5 º.  
 








General procedure 4 was employed with 5-chloro-3-methylbenzo[b]thiophene (54.6 mg, 0.3 
mmol, 1.0 equiv), potassium (R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% 
ee), precatalyst (16.6 mg, 0.015 mmol, 5 mol %) and additional ligand (11.0 mg, 0.015 mmol, 5 
mol %). The reaction mixture was heated to 100 ºC for 48 h. A colorless liquid (33.6 mg, 55% 
yield, 90% ee) was isolated following column chromatography (100% hexane). A duplicate run 
of the enantioenriched variant on 0.05 mmol scale afforded the product with 90% ee. 1H NMR 
(300 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 1H), 7.50 (s, 1H), 7.20 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz, 
1H), 7.04 (s, 1H), 2.74 (sextet, J = 7.1 Hz), 2.44 (d, J = 1.1Hz, 3H), 1.67 (quintet, J = 7.4 Hz, 
2H), 1.31 (d, J = 7.0 Hz, 3H), 0.85 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.8, 
140.0, 138.0, 132.2, 124.0, 122.7, 121.7, 120.0, 42.1, 31.7, 22.5, 14.1, 12.6 ppm. Optical rotation 
of this product [α]25D (c 1.00, CHCl3) = -21.1 º.  
 
 (S)-5-(sec-butyl)-3- methylbenzo[b]thiophene (Table 4-1, (S)-23b). 
General procedure 5 was employed with 5-chloro-3-
methylbenzo[b]thiophene (54.6 mg, 0.3 mmol, 1.0 equiv) and potassium 
(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was 
heated to 100 ºC for 24 h. A colorless liquid (51 mg, 83% yield, 97% ee) was isolated following 
column chromatography (100 % hexane). A duplicate run of the enantioenriched variant on 0.05 
mmol scale afforded the product with 94% ee. 1H NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3 
Hz, 1H), 7.50 (s, 1H), 7.20 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz, 1H), 7.04 (s, 1H), 2.74 (sextet, J = 7.1 
Hz), 2.44 (d, J = 1.1Hz, 3H), 1.67 (quintet, J = 7.4 Hz, 2H), 1.31 (d, J = 7.0 Hz, 3H), 0.85 (t, J = 
7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.8, 140.0, 138.0, 132.2, 124.0, 122.7, 121.7, 









(Table 2, 6g).  
General procedure 1 was employed using 6-chloroquinoline (82 mg, 0.5 
mmol) and iso-propylboronic acid (66 mg, 0.75 mmol). A yellow liquid 
(run 1: 70 mg, 82%; run 2: 69 mg, 81%) was isolated by column chromatography (80:20 
Hex/ether). 1H NMR (500 MHz, CDCl3): δ 8.86 (dd, J = 4.2, 2.0 Hz, 1H), 8.11 (d, J = 8.6 Hz, 
1H), 8.04 (d, J = 8.6 Hz, 1H), 7.63 (dd, J = 8.7, 1.8 Hz, 1H), 7.60 (s, 1H), 7.35 (dd, J = 8.3, 4.2 
Hz, 1H), 3.11 (septet, J = 6.9 Hz, 1H), 1.34 (d, J = 6.9 Hz, 6H) ppm. 13C NMR (125 MHz, 
CDCl3): δ 149.6, 147.18, 147.17, 135.8, 129.5, 129.3, 128.4, 123.9, 121.1, 34.1, 23.9 ppm. 
 
(Table 2, 6g’): General procedure 1 was employed using 6-chloroquinoline (82 mg, 0.5 mmol) 
and potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A yellow liquid (run 1: 70 mg, 





(Table 2, 7g).  
General procedure 1 was employed using 6-chloroquinoline (82 mg, 0.5 
mmol) and sec-butylboronic acid (77 mg, 0.75 mmol). A yellow liquid (run 
1: 77 mg, 83%; run 2: 71 mg, 76%) was isolated by column chromatography (85:15 Hex/ether to 
80:20 Hex/ether gradient). 1H NMR (500 MHz, CDCl3): δ 8.86 (dd, J = 4.1, 1.6 Hz, 1H), 8.11 (d, 
J = 8.3 Hz, 1H), 8.04 (d, J = 8.6 Hz, 1H), 7.59 (m, 2H), 7.37 (dd, J = 8.3, 4.2 Hz, 1H), 2.80 (m, 








CDCl3): δ 149.7, 147.3, 146.0, 135.8, 129.6, 129.3, 128.4, 125.0, 121.1, 41.7, 31.1, 21.9, 12.4 
ppm.  
 
(Table 2, 7g’): General procedure 1 was employed using 6-chloroquinoline (82 mg, 0.5 mmol) 
and potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A yellow liquid (run 1: 70 mg, 
76%; run 2: 63 mg, 74%) was isolated by column chromatography (85:15 Hex/ether to 80:20 
Hex/ether gradient).  
 
 tert-Butyl 6-isopropyl-1H-indole-1-carboxylate (Table 2, 6h).  
General procedure 1 was employed using 1-(tert-butoxycarbonyl)-6-
chloroindole (126 mg, 0.5 mmol) and iso-propylboronic acid (66 mg, 0.75 
mmol). A colorless liquid (run 1: 110 mg, 85%; run 2: 113 mg, 87%) was isolated by column 
chromatography (98:2 Hex/ether). Peaks of major rotamer given: 1H NMR (500 MHz, CDCl3): δ 
8.06 (br s, 1H), 7.53 (br s, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.12 (d, J = 8.0, 1.1 Hz, 1H), 6.52 (d, J 
= 3.6 Hz, 1H), 3.04 (septet, J = 6.9 Hz, 1H), 1.68 (s, 9H), 1.32 (d, J = 6.9 Hz, 6H) ppm. 13C 
NMR (125 MHz, CDCl3): δ 150.1, 145.7, 128.8, 126.0, 125.6, 121.9, 120.8, 112.9, 107.3, 83.6, 
34.8, 28.4, 24.7 ppm. HRMS (FAB+): Calcd (M+) 259.1572; Found 259.1586.  
 
(Table 2, 6h’): General procedure 1 was employed using 1-(tert-butoxycarbonyl)-6- chloroindole 
(126 mg, 0.5 mmol) and potassium iso-propyltrifluoroborate (112 mg, 0.75 mmol). A colorless 








tert-Butyl 6-(sec-butyl)-1H-indole-1-carboxylate (Table 2, 7h). General 
procedure 1 was employed using 1-(tert-butoxycarbonyl)-6-chloroindole 
(126 mg, 0.5 mmol) and sec-butylboronic acid (77 mg, 0.75 mmol). A 
colorless liquid (run 1: 125 mg, 92%; run 2: 121 mg, 89%) was isolated by column 
chromatography (98:2 Hex/ether). Peaks of major rotamer given: 1H NMR (500 MHz, CDCl3): δ 
8.01 (br s, 1H), 7.52 (br s, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.07 (dd, J = 8.0, 1.2 Hz, 1H), 6.52 (d, J 
= 3.6 Hz, 1H), 2.72 (app. sextet, J = 7.0 Hz, 1H), 1.66 (s, 9H), 1.65 (m, 2H), 1.29 (d, J = 6.9 Hz, 
3H), 0.84 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 150.1, 144.5, 128.8, 125.5, 
122.4, 120.7, 113.7, 107.3, 83.5, 43.4, 31.7, 28.4, 28.3, 22.6 ppm. HRMS (FAB+): Calcd (M+) 
273.1729; Found 273.1740.  
 
(Table 2-3, 7h’): General procedure 1 was employed using 1-(tert-butoxycarbonyl)-6- 
chloroindole (126 mg, 0.5 mmol) and potassium sec-butyltrifluoroborate (123 mg, 0.75 mmol). A 
colorless liquid (run 1: 126 mg, 93%; run 2: 122 mg, 89%; run 3: 133 mg, 97%) was isolated by 




4, 10a). General procedure 2 was employed using 5-chloro-3-
methyl-1-benzothiophene (91 mg, 0.5 mmol) and potassium (4-
phenylbutan-2-yl)trifluoroborate (180 mg, 0.75 mmol). A pale yellow, waxy solid (run 1: 109 
mg, 78%; run 2: 120 mg, 86%) was isolated by column chromatography (99.5:0.5 Hex/ether) 1H 









Hz, 1H), 7.17 (t, J = 7.4 Hz, 1H), 7.14 (d, J = 7.8 Hz, 2H), 7.07 (s, 1H), 2.87 (app. sextet, J = 7.2 
Hz, 1H), 2.53 (m, 2H), 2.44 (s, 3H), 1.99 (m, 2H), 1.34 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (125 
MHz, CDCl3): δ 143.4, 142.7, 140.1, 138.1, 132.2, 128.6, 128.5, 125.9, 123.9, 122.9, 121.9, 
120.2 40.4, 39.9, 34.2, 23.3, 14.3 ppm. HRMS (FAB+): Calcd (M+) 280.1286; Found 280.1292.  
 
2,4-Dimethyl-1-(4-phenylbutan-2-yl)benzene (Table 2-4, 10b). 
General procedure 2 was employed using 1-chloro-2,4-
dimethylbenzene (67 µL, 0.5 mmol) and potassium (4-  
phenylbutan-2-yl)trifluoroborate (180 mg, 0.75 mmol). A pale yellow liquid (run 1: 97 mg, 81%; 
run 2: 100 mg, 84%) was isolated by column chromatography (99:1 Hex/ether). 1H NMR (500 
MHz, CDCl3): δ 7.27 (m, 2H), 7.17 (t, J = 7.4 Hz, 1H), 7.14 (m, 3H), 7.02 (d, J = 7.7 Hz, 1H), 
6.97 (s, 1H), 2.95 (app. sextet, J = 7.0 Hz, 1H), 2.55 (m, 2H), 2.30 (s, 3H), 2.22 (s, 3H), 1.94 (m, 
1H), 1.88 (m, 1H), 1.22 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3), δ 142.8, 142.5, 
135.5, 135.1, 131.3, 128.6, 128.5, 127.1, 125.8, 125.3, 39.5, 34.1, 33.8, 22.1, 21.1, 19.6 ppm. 
HRMS (FAB+): Calcd (M+) 238.1722; Found 238.1731.  
 
Ethyl 4-(4-phenylbutan-2-yl)benzoate (Table 2-4, 10c). General 
procedure 2 was employed using ethyl 4-chlorobenzoate (92 mg, 
0.5 mmol) and potassium (4- phenylbutan-2-yl)trifluoroborate (180 
mg, 0.75 mmol). A pale yellow liquid (run 1: 98 mg, 78%; run 2: 100 mg, 71%)) was isolated by 
chromatography (98:2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.99 (d, J = 8.3 Hz, 2H), 7.25-
7.28 (m, 4H), 7.17 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 7.5 Hz, 2H), 4.37 (q, J = 7.1 Hz, 2H), 2.78 (m, 








NMR (125 MHz, CDCl3), δ 166.8, 152.8, 142.3, 129.96, 129.95, 128.50, 128.49, 127.3, 125.9, 




(Table 2-4, 10d). General procedure 2 was employed using 1-(tert-
butoxycarbonyl)-6-chloroindole (126 mg, 0.5 mmol) and potassium 
(4-phenylbutan-2-yl)trifluoroborate (180 mg, 0.75 mmol). A colorless liquid (run 1: 103 mg, 
59%; run 2: 95 mg, 55%) was isolated by column chromatography (97:3 Hex/ether). Peaks of 
major rotamer given: 1H NMR (500 MHz, CDCl3): δ 8.04 (br s, 1H), 7.54 (br s, 1H), 7.49 (d, J = 
8.0 Hz, 1H), 7.26 (m, 2H), 7.16 (m, 3H), 7.10 (dd, J = 8.0, 1.2 Hz, 1H), 6.53 (d, J = 3.6 Hz, 1H), 
2.85 (m, 1H), 2.53 (m, 2H), 1.97 (m, 2H), 1.67 (s, 9H), 1.33 (d, J = 7.0 Hz, 3H) ppm. 13C NMR 
(125 MHz, CDCl3), δ 150.0, 144.0, 142.8, 128.9, 128.6, 128.4, 125.8, 125.6, 122.3, 120.9, 113.7, 
107.3, 83.55, 40.6, 40.2, 34.2, 28.4, 23.2 ppm. HRMS (FAB+): Calcd (M+) 349.2042; Found 
349.2038.  
 
 2-Methyl-8-(4-phenylbutan-2-yl)quinolone (Table 2-4, 10e). 
General procedure 2 was employed using 8-chloro-2-
methylquinoline (89 mg, 0.50 mmol) and potassium (4- 
phenylbutan-2-yl)trifluoroborate (180 mg, 0.75 mmol). A light brown liquid (run 1: 74 mg, 54%; 
run 2: 65 mg, 48%) was isolated by column chromatography (96:4 Hex/ether). 1H NMR (500 
MHz, CDCl3): δ 8.06 (d, J = 8.4 Hz, 1H), 7.66 (m, 2H), 7.52 (t, J = 7.6 Hz, 1H), 7.33 (m, 3H), 







(m, 1H), 2.08 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 157.7, 
146.1, 145.6, 143.3, 136.5, 128.6, 128.3, 126.6, 125.8, 125.64, 125.60, 125.5, 121.7, 40.2, 34.3, 
32.0, 25.9, 22.0 ppm. HRMS (FAB+): Calcd (M+H+) 276.1752; Found 276.1753.  
 
 (S)-2-Methyl-8-(4-phenylbutan-2-yl)quinolone (Table 4-1, 26c). 
General procedure B was employed with 8- chloro-2-
methylquinoline (53.3 mg, 0.3 mmol, potassium 4-phenylbut-2-yl 
trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3% 
ee), and toluene/water (600 uL/ 600uL). A slightly yellow liquid (run 1 (racemic): 55.8 mg, 68% 
yield; run 2 (enantioenriched): 45.5 mg, 55% yield, 90% ee) was isolated following column 
chromatography (97:3 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 
mmol scale afforded the product with 89% ee. 1H NMR (300 MHz, CDCl3): δ 8.01 (d, J = 8.3 
Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 7.24 (t, J = 
8.3 Hz, 3H), 7.19-7.10 (m, 3H), 4.37 (sextet, J = 7.0 Hz, 1H), 2.73 (s, 3H), 2.69-2.47 (m, 2H), 
2.23-2.07 (m, 1H), 2.07-1.91 (m, 1H), 1.40 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 157.6, 146.2, 145.7, 143.3, 136.4 128.6, 128.3, 126.6, 125.9, 125.6, 125.6, 125.4, 
121.6, 40.1, 34.4, 32.1, 25.8, 21.9 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -
80.9 º.  
 
Ethyl 4-(1-phenylpropan-2-yl)benzoate (Table 2-4, 10f). General 
procedure 2 was employed using ethyl 4-chlorobenzoate (92 mg, 0.5 
mmol) and potassium (1- phenylpropan-2-yl)trifluoroborate (170 mg, 







chromatography (98:2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.94 (d, J = 8.2 Hz, 2H), 7.22 
(m, 4H) 7.17 (t, J = 7.2 Hz, 1H), 7.04 (d, J = 7.5 Hz, 2H), 4.35 (q, J = 7.1 Hz, 2H), 3.06 (m, 1H), 
2.91 (dd, J = 13.4 Hz, 7.0 Hz, 1H), 2.81 (dd, J = 13.4 Hz, 7.8 Hz, 1H), 1.38 (t, J = 7.1 Hz, 3H), 
1.27 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3), δ 166.8, 152.3, 140.3, 129.8, 129.2, 
128.5, 128.3, 127.2, 126.1, 60.9, 44.9, 42.2, 21.2, 14.5 ppm. HRMS (FAB+): Calcd (M+H+) 




(Table 2-4, 10g). General procedure 
1 was employed using 1-chloro-4-nitrobenzene (79 mg, 0.5 mmol) and 
potassium cyclopropyltrifluoroborate (111 mg, 0.75 mmol). A yellow oil 
(run 1: 77 mg, 95%; run 2: 78 mg, 96%) was isolated by column chromatography (98:2 
Hex/ether). 1H NMR (500 MHz, CDCl3): δ 8.09 (d, J = 8.4 Hz, 2H), 7.14 (d, J = 8.8 Hz, 2H), 
1.98 (m, 1H), 1.12 (m, 2H), 0.81 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 152.9, 145.8, 





(Table 2-4, 10h). General 
procedure 1 was employed using 1-(4-chlorophenyl)-1H-pyrrole (89 
mg, 0.5 mmol) and potassium cyclobutyltrifluoroborate (122 mg, 0.75 
mmol). An off-white solid (run 1: 82 mg, 84%; run 2: 87 mg, 88%) was isolated by column 
chromatography (98:2 Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.31 (s, 2H), 7.27 (s, 2H), 7.07 
(s, 2H), 6.34 (s, 2H), 3.56 (quintet, J = 8.6 Hz, 1H), 2.36 (m, 2H), 2.15 (m, 2H), 2.05 (dt, J = 




138.8, 127.5, 120.7, 119.6, 110.2, 40.0, 30.1, 18.4 ppm.  
 
 6-Cyclopentylquinoline (Table 2-4, 10i). General procedure 1 was 
employed using 6- chloroquinoline (82 mg, 0.5 mmol) and potassium 
cyclopentyltrifluoroborate (132 mg, 0.75 mmol). A slightly brown 
liquid (run 1: 86 mg, 87%; run 2: 86 mg, 87%) was isolated by column chromatography (70:30 
Hex/ether). 1H NMR (500 MHz, CDCl3): δ 8.81 (dd, J = 4.1, 1.4 Hz, 1H), 8.03 (d, J = 8.0, 1H), 
8.02 (d, J = 8.6, 1H), 7.59 (d, J = 8.7 Hz, 1H), 7.57 (s, 1H), 7.29 (dd, J = 8.2, 4.2 Hz, 1H), 3.12 
(m, 1H), 2.09-2.11 (m, 2H), 1.80-1.82 (m, 2H), 1.64-1.70 (m, 4H) ppm. 13C NMR (125 MHz, 
CDCl3): δ 149.6, 147.2, 144.9, 135.7, 129.9, 129.2, 128.3, 124.6, 121.1, 45.9, 34.6, 25.6 ppm. 




(Table 2-4, 10j). General 
procedure 1 was employed using 3-chloroanisole (71 mg, 0.5 mmol) 
and potassium cyclohexyltrifluoroborate (143 mg, 0.75 mmol). A pale 
yellow oil (run 1: 81 mg, 85%; run 2: 90 mg, 95%) was isolated by column chromatography 
(99:1-97:3 gradient of Hex/ether). 1H NMR (500 MHz, CDCl3): δ 7.21 (t, J = 7.9 Hz, 1H), 6.81 
(d, J = 7.5 Hz, 1H), 6.76 (s, 1H), 6.72 (d, J = 8.2 Hz, 1H), 3.80 (s, 3H), 2.48 (m, 1H), 1.72-1.87 
(m, 5H), 1.40 (m, 5H) ppm. 13C NMR (125 MHz, CDCl3): δ 159.8, 150.0, 129.4, 119.5, 113.0, 
111.0, 55.3, 44.9, 34.6, 27.1, 26.4 ppm.  
 
 Racemic or (R)-4-(sec-butyl)-1,1'-biphenyl (Table 4-1, (R)-23c).[24]
 






mmol, 1.0 equiv) and potassium sec-butyltrifluoroborate or potassium (R)-sec-
butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was heated 
to 100 ºC for 24 h. A colorless liquid (run 1 (racemic): 57.8 mg, 92% yield; run 2 
(enantioenriched): 55.6 mg, 88% yield, 90% ee) was isolated following column chromatography 
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the 
product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 7.8 Hz, 2H), 7.58 (d, J = 8.2 
Hz, 2H), 7.51-7.41 (m, 2H), 7.41-7.34 (m, 1H), 7.31 (d, J = 8.1Hz, 2H), 2.70 (sextet, J = 7.0 Hz, 
1H), 1.69 (quintet, J = 7.0 Hz, 2H), 1.33 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H) ppm. 13C 
NMR (75 MHz, CDCl3): δ 147.0, 141.4, 138.9, 128.9, 127.7, 127.2, 127.1, 41.6, 31.4, 22.0, 12.5 
ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -23.9 º.  
 
 Racemic (or (S)-)4-(sec-butyl)-1,1'-biphenyl (Table 4-1, (S)-23c).[24] 
General procedure 5 was employed with 4-chlorobiphenyl (56.4 mg, 0.3 
mmol, 1.0 equiv) and potassium sec- butyltrifluoroborate or potassium 
(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). 
The reaction mixture was heated to 80 oC for 24 h. A colorless liquid (run 1 (racemic): 57.8 mg, 
92% yield; run 2 (enantioenriched): 58.4 mg, 93% yield, 96% ee) was isolated following column 
chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol 
scale afforded the product with 96% ee. 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 7.8 Hz, 2H), 
7.58 (d, J = 8.2 Hz, 2H), 7.51-7.41 (m, 2H), 7.41-7.34 (m, 1H), 7.31 (d, J = 8.1Hz, 2H), 2.70 
(sextet, J = 7.0 Hz, 1H), 1.69 (quintet, J = 7.0 Hz, 2H), 1.33 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.3 
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 147.0, 141.4, 138.9, 128.9, 127.7, 127.2, 127.1, 





 Racemic or (R)-1-methoxy-2-(4-phenylbutan-2- yl)benzene (Table 
4-1, (R)-23d).[25] General procedure 3 was employed with 1-chloro-2-
methoxybenzene (38.1 µL, 0.3 mmol, 1.0 equiv) and potassium 4-
phenylbut-2-yl trifluoroborate or potassium (R)-4- phenylbut-2-yl 
trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee). The reaction mixture was heated to 100 ºC for 
36 h (48 h for reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 
62.8 mg, 87 % yield; run 2 (enantioenriched): 61.6 mg, 86% yield, 93% ee) was isolated 
following column chromatography (98:2 hexane/ether). A duplicate run of the enantioenriched 
variant on 0.05 mmol scale afforded the product with 93% ee. 1H NMR (300 MHz, CDCl3): δ 
7.30-7.19 (m, 3H), 7.19-7.11 (m, 4H), 6.94 (dt, J1= 7.4 Hz, J2= 1.1 Hz, 1H), 6.87 (dd, J1= 8.1 Hz, 
J2= 0.9 Hz, 1H), 3.81 (s, 3H), 3.25 (sextet, J = 7.2 Hz, 1H), 2.68-2.44 (m, 2H), 2.05-1.91 (m, 
1H), 1.91-1.76 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.2, 
143.1, 135.6, 128.5, 128.3, 126.9, 126.8, 125.6, 120.8, 110.6, 55.4, 39.0, 34.2, 32.0, 21.1 ppm. 
HRMS: Calcd (M+H+) 241.1592; Found 241.1603. Optical rotation of this product [α]25D(c 1.00, 
CHCl3) = +16.6 º.  
 
 Racemic or (S)-1-methoxy-2-(4-phenylbutan-2- yl)benzene (Table 
4-1, (S)-23d).[25]General procedure 5 was employed with 1-chloro-2- 
methoxybenzene (38.1 µL, 0.3 mmol, 1.0 equiv) and potassium 4-
phenylbut-2-yl trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 
mmol, 96.3% ee). The reaction mixture was heated to 100 ºC for 24 h (48 h for reaction with 






(enantioenriched): 62.3 mg, 87% yield, 94% ee) was isolated following column chromatography 
(98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded 
the product with 95% ee. 1H NMR (300 MHz, CDCl3): δ 7.30-7.19 (m, 3H), 7.19-7.11 (m, 4H), 
6.94 (dt, J1 = 7.4 Hz, J2 = 1.1 Hz, 1H), 6.87 (dd, J1 = 8.1 Hz, J2 = 0.9 Hz, 1H), 3.81 (s, 3H), 3.25 
(sextet, J = 7.2 Hz, 1H), 2.68-2.44 (m, 2H), 2.05-1.91 (m, 1H), 1.91-1.76 (m, 1H), 1.24 (d, J = 
7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.2, 143.1, 135.6, 128.5, 128.3, 126.9, 126.8, 
125.6, 120.8, 110.6, 55.4, 39.0, 34.2, 32.0, 21.1 ppm. HRMS: Calcd (M+H+) 241.1592; Found 
241.1603. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -17.8 º.  
 
 Racemic or ethyl (R)-4-(sec-butyl)benzoate[26] (Table 4-1, (R)-23f). 
General procedure 3 was employed with (49.0 µL, 0.3 mmol, 1.0 equiv) 
ethyl 4-bromobenzoate and potassium sec-butyltrifluoroborate or 
potassium (R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction 
mixture was heated to 100 ºC and stirred for 24 h (36 h with enantioenriched nucleophile). A 
colorless liquid (run 1 (racemic): 52.0 mg, 84% yield; run 2 (enantioenriched): 53.5 mg, 87% 
yield, 92% ee) was isolated following column chromatography (95:5 hexane/ether). A duplicate 
run of the enantioenriched variant on 0.05 mmol scale afforded the product with 92% ee. 1H 
NMR (300 MHz, CDCl3): δ 7.96 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 4.36 (q, J = 7.1 
Hz, 2H), 2.66 (sextet, J = 6.9 Hz, 1H), 1.61 (quintet, J = 7.3 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H), 
1.25 (d, J = 6.9 Hz, 3H), 0.81(t, J = 7.4Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.8, 
153.2, 129.8, 128.4, 127.2, 60.8, 41.9, 31.1, 21.8, 14.5, 12.3 ppm. Optical rotation of this product 






 Racemic or (S)-ethyl 4-(sec-butyl)benzoate[26] (Table 4-1, (S)-23f). 
General procedure 5 was employed with ethyl 4-chlorobezoate (46.7 
µL, 0.3 mmol, 1.0 equiv) and potassium sec- butyltrifluoroborate or 
potassium (R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction 
mixture was heated to 60 ºC and stirred for 24 h (30 h with enantioenriched nucleophile). A 
colorless liquid (run 1 (racemic): 55.3 mg, 89% yield; run 2 (enantioenriched): 53 mg, 86% 
yield, 96% ee) was isolated following column chromatography (95:5 hexane/ether). A duplicate 
run of the enantioenriched variant on 0.05 mmol scale afforded the product with 93% ee. 1H 
NMR (300 MHz, CDCl3): δ 7.96 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 4.36 (q, J = 7.1 
Hz, 2H), 2.66 (sextet, J = 6.9 Hz, 1H), 1.61 (quintet, J = 7.3 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H), 
1.25 (d, J = 6.9 Hz, 3H), 0.81(t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.8, 
153.2, 129.8, 128.4, 127.2, 60.8, 41.9, 31.1, 21.8, 14.5, 12.3 ppm. Optical rotation of this product 
[α]25D (c 1.00, CHCl3) = +24.1 º.  
 
 Racemic or (R)-butane-1,3-diyldibenzene (Table 4-1, (R)-23h). 
General procedure 4 was employed with chlorobenzene (30.4 µL, 0.3 
mmol, 1.0 equiv) and potassium 4-phenylbut-2-yl trifluoroborate or 
potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 
96.3% ee). The reaction mixture was heated to 100 ºC and stirred for 24 h (30 h with 
enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 46.6 mg, 74% yield; run 2 
(enantioenriched): 40.5 mg, 64% yield, 91% ee) was isolated following column chromatography 
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the 






7.17-7.10 (m, 2H), 2.72 (sextet, J = 7.0 Hz, 1H), 2.51 (m, 2H), 2.00-1.83 (m, 2H), 1.28 (d, J = 
6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 147.5, 142.7, 128.6, 128.6, 128.5, 127.3, 126.2, 
125.8, 40.2, 39.7, 34.1, 22.7 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -14.4 
º.  
 
 Racemic or (S)-butane-1, 3-diyldibenzene (Table 4-1, (S)- 23h). 
General procedure 5 was employed with chlorobenzene (30.4 µL, 0.3 
mmol, 1.0 equiv) and potassium 4-phenylbut-2-yl trifluoroborate or 
potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 
96.3% ee). The reaction mixture was heated to 80 ºC and stirred for 24 h. A colorless liquid (run 
1 (racemic): 55.8 mg, 89% yield; run 2 (enantioenriched): 49 mg, 78% yield, 89% ee) was 
isolated following column chromatography (100 % hexane). A duplicate run of the 
enantioenriched variant on 0.05 mmol scale afforded the product with 88% ee. 1H NMR (300 
MHz, CDCl3): δ 7.35-7.26 (m, 3H), 7.25-7.17 (m, 5H), 7.17-7.10 (m, 2H), 2.72 (sextet, J = 7.0 
Hz, 1H), 2.51 (m, 2H), 2.00-1.83 (m, 2H), 1.28 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 147.5, 142.7, 128.6, 128.6, 128.5, 127.3, 126.2, 125.8, 40.2, 39.7, 34.1, 22.7 ppm. 
Optical rotation of this product [α]25D (c 1.00, CHCl3) = +13.5 º.  
 
 Racemic or (R)-1-(4-phenylbutan-2-yl)-4- (trifluoromethyl)benzene 
(Table 4-1, (R)-23i).[27]General procedure 3 was employed with 4- 
bromobenzotrifluoride (42.0 µL, 0.3 mmol, 1.0 equiv) and potassium 4-
phenylbut-2-yl trifluoroborate or potassium (R)-4-phenylbut-2-yl 





stirred for 30 h (48 h with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 72.3 
mg, 87% yield; run 2 (enantioenriched): 62.7 mg, 75% yield, 91% ee) was isolated following 
column chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 
mmol scale afforded the product with 91% ee. 1H NMR (300 MHz, CDCl3): δ 7.56 (d, J = 8.1 
Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 7.26-7.22 (m, 2H), 7.21-7.16 (m, 1H), 7.15-7.08 (m, 2H), 2.79 
(sextet, J = 7.0 Hz, 1H), 2.55-2.46 (m, 2H), 1.93 (q, J = 7.8 Hz, 2H), 1.29 (d, J = 6.9 Hz, 3H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 151.2, 142.3, 128.6, 128.6, 127.6, 126.0, 125.6(q), 39.9, 
39.6, 34.0, 22.4 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -16.1 º.  
 
 Racemic or (S)-1-(4-phenylbutan-2-yl)-4- 
(trifluoromethyl)benzene (Table 4-1, (S)-23i).[27]General procedure 
5 was employed with 4- chlorobenzotrifluoride (40.0 µL, 0.3 mmol, 
1.0 equiv) and potassium 4-phenylbut-2-yl trifluoroborate or 
potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee). The reaction 
mixture was heated to 60 ºC and stirred for 24 h. A colorless liquid (run 1 (racemic): 73.7 mg, 
88% yield; run 2 (enantioenriched): 67 mg, 80% yield, 87% ee) was isolated following column 
chromatography (hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale 
afforded the product with 86% ee. 1H NMR (300 MHz, CDCl3): δ 7.56 (d, J = 8.1 Hz, 2H), 7.31 
(d, J = 8.6 Hz, 2H), 7.26-7.22 (m, 2H), 7.21-7.16 (m, 1H), 7.15-7.08 (m, 2H), 2.79 (sextet, J = 
7.0 Hz, 1H), 2.55-2.46 (m, 2H), 1.93 (q, J = 7.8 Hz, 2H), 1.29 (d, J = 6.9 Hz, 3H) ppm. 13C NMR 
(75 MHz, CDCl3): δ 151.2, 142.3, 128.6, 128.6, 127.6, 126.0, 125.6(q), 39.9, 39.6, 34.0, 22.4 





 Racemic or (R)-2-methyl-5-(3-(4- 
(trifluoromethyl)phenyl)butyl)thiophene (Table 4-1, (R)-23j). 
General procedure 3 was employed with 4-bromobenzotrifluoride 
(14.0 µL, 0.1 mmol, 1.0 equiv), potassium 4-(5-methylthiophen-2-
yl)but-2-yl trifluoroborates or potassium (R)-4- (5-methylthiophen-2-yl)but-2-yl trifluoroborate 
(39.0 mg, 0.15 mmol, 1.5 equiv, 95% ee), precatalyst (5.2 mg, 0.005 mmol, 5 mol %), additional 
ligand (3.4 mg, 0.005 mmol, 5 mol %), and toluene/ water (200 uL/200uL). The reaction mixture 
was heated to 100 ºC for 24 h (48 h for reaction with enantioenriched nucleophile). A colorless 
liquid (run 1 (racemic): 13.9 mg, 47% yield; run 2 (enantioenriched): 13.5 mg, 45% yield, 94% 
ee) was isolated following column chromatography (100 % hexane). A duplicate run of the 
enantioenriched variant on 0.05 mmol scale afforded the product with 94% ee. 1H NMR (300 
MHz, CDCl3): δ 7.57 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.56-6.52 (m, 1H), 6.50 (d, J 
= 3.3 Hz, 1H), 2.85 (sextet, J = 7.11 Hz, 1H), 2.64 (t, J = 7.3 Hz, 2H), 2.44 (s, 3H), 1.96 (q, J = 
7.7 Hz, 2H), 1.29 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 151.2, 142.7, 137.5, 
127.6, 125.5(q), 124.7, 124.0, 39.9, 39.2, 28.1, 22.2, 15.4 ppm. HRMS: Calcd (M+Na+) 
321.0901; Found 321.0906. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -29.8 º.  
 
 Racemic or (S)-2-methyl-5-(3-(4- 
(trifluoromethyl)phenyl)butyl)thiophene (Table 4-1, (S)-
23j).General procedure 5 was employed with 4-
chlorobenzotrifluoride (13.3 µL, 0.1 mmol, 1.0 equiv), potassium 4-
(5-methylthiophen-2- yl)but-2-yl trifluoroborates or potassium (R)-4-(5-methylthiophen-2-










mmol, 10 mol %) and toluene/ water (200 uL/200uL). The vessel was heated to 60 ºC for 24 h 
(48 h for reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 17.8 
mg, 60% yield; run 2 (enantioenriched): 15.7 mg, 53% yield, 90% ee) was isolated following 
column chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 
mmol scale afforded the product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.57 (d, J = 8.1 
Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.56-6.52 (m, 1H), 6.50 (d, J = 3.3 Hz, 1H), 2.85 (sextet, J = 
7.1 Hz, 1H), 2.64 (t, J = 7.3 Hz, 2H), 2.44 (s, 3H), 1.96 (q, J = 7.7 Hz, 2H), 1.29 (d, J = 6.9 Hz, 
3H) ppm. 13C NMR (75 MHz, CDCl3): δ 151.2, 142.7, 137.5, 127.6, 125.5(q), 124.7, 124.0, 39.9, 
39.2, 28.1, 22.2, 15.4 ppm. HRMS: Calcd (M+Na+) 321.0901; Found 321.0906. Optical rotation 
of this product [α]25D (c 1.00, CHCl3) = +26.9 º.  
 
Racemic or (R)-ethyl-4-(4-phenoxybutan-2- yl)benzoate (Table 4-
1, (R)-23k).General procedure 3 was employed with ethyl 4- 
bromobenzoate (16.3 µL, 0.1 mmol, 1.0 equiv), potassium 4-
phenoxybut-2-yl trifluoroborate or potassium (R)-4-phenoxybut-2-yl 
trifluoroborate (38.4 mg, 0.15 mmol, 1.5 equiv, 98% ee), precatalyst (5.2 mg, 0.005 mmol, 5 
mol %), additional ligand (3.4 mg, 0.005 mmol, 5 mol %), and toluene/ water (200 uL/ 200uL). 
The reaction mixture was heated to 100 ºC for 24 h (48 h for reaction with enantioenriched 
nucleophile). A colorless liquid (run 1 (racemic): 13.2 mg, 44% yield; run 2 (enantioenriched): 
15.2 mg, 51% yield, 95% ee) was isolated following column chromatography (95:5 
hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the 
product with 96% ee. 1H NMR (300 MHz, CDCl3): δ 7.98 (td, J1 = 8.3 Hz, J2 = 1.5 Hz, 2H), 




2H), 3.92-3.73 (m, 2H), 3.10 (sextet, J = 6.9 Hz, 1H), 2.20-1.98 (m, 2H), 1.39 (t, J = 7.1 Hz, 
3H), 1.34 (d, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.7, 159.0, 152.0, 130.0, 129.5, 
128.7, 127.2, 120.8, 114.6, 65.7, 60.9, 37.5, 36.6, 22.2, 14.5 ppm. HRMS: Calcd (M+Na+) 
321.1467; Found 321.1461. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -90.2 º.  
 
Racemic or (S)-ethyl-4-(4-phenoxybutan-2- yl)benzoate (Table 4-
1, (S)-23k).General procedure 5 was employed with ethyl 4- 
chlorobenzoate (15.5 µL, 0.1 mmol, 1.0 equiv), potassium 4-
phenoxybut-2-yl trifluoroborate potassium or (R)-4-phenoxybut-2-yl 
trifluoroborate (38.4 mg, 0.15 mmol, 0.15 equiv, 98% ee), precatalyst (12 mg, 0.015 mmol, 15 
mol %) and toluene/water (200 uL/ 200 uL). The reaction mixture was heated to 60 ºC for 48 h. 
A colorless liquid (run 1 (racemic): 16.1 mg, 54% yield; run 2 (enantioenriched): 15.8 mg, 53% 
yield, 71% ee) was isolated following column chromatography (95:5 hexane/ether). A duplicate 
run of the enantioenriched variant on 0.05 mmol scale afforded the product with 75% ee. 1H 
NMR (300 MHz, CDCl3): δ 7.98 (td, J1 = 8.3 Hz, J2 = 1.5 Hz, 2H), 7.32-7.21 (m, 4H), 6.92 (tt, 
J1 = 7.4 Hz, J2 = 1.0 Hz, 1H), 6.86-680 (m, 2H), 4.37 (q, J = 7.1 Hz, 2H), 3.92-3.73 (m, 2H), 
3.10 (sextet, J = 6.9 Hz, 1H), 2.20-1.98 (m, 2H), 1.39 (t, J = 7.1 Hz, 3H), 1.34 (d, J = 7.0 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 166.7, 159.0, 152.0, 130.0, 129.5, 128.7, 127.2, 120.8, 
114.6, 65.7, 60.9, 37.5, 36.6, 22.2, 14.5 ppm. HRMS: Calcd (M+Na+) 321.1467; Found 






(R)-4-(1-phenylpentan-3-yl)-1,1'-biphenyl (Table 4-1, (R)-23j). 
General procedure 4 was employed with ethyl 4-chlorobiphenyl (18.9 
mg, 0.1 mmol, 1.0 equiv), potassium 1-phenypentan-3-yl 
trifluoroborate potassium or (R)-4-1-phenypentan-3-yl trifluoroborate 
(38.0 mg, 0.15 mmol, 0.15 equiv, 98% ee), precatalyst (5.54 mg, 0.05 mmol, 5 mol %), 
additional ligand (3.68 mg, 5 mol %) and toluene/water (200 uL/ 200 uL). The reaction mixture 
was heated to 100 ºC for 24 h. A colorless oil (run 1 (racemic): 23.7 mg, 79% yield; run 2 
(enantioenriched): 22.6 mg, 75% yield, 97% ee) was isolated following column chromatography 
(99:1 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded 
the product with 97 % ee. 1H NMR (300 MHz, CD2Cl2): δ 7.67-7.61 (m, 2H), 7.61-7.55 (d, 
J=8.2 Hz, 2H), 7.45 (t, J=7.2 Hz, 2H), 7.38-7.31 (m, 1H), 7.26 (t, J=8.0 Hz, 4H), 7.20-7.12 (m, 
3H), 2.58-2.45 (m, 1H), 2.50 (t, J=7.8 Hz, 2H), 2.09-1.85 (m, 2H), 1.85-1.57 (m, 2H), 0.82 (t, 
J=7.3 Hz, 3H) ppm. 13C NMR (75 MHz, CD2Cl2): δ 145.2, 143.2, 141.5, 139.1, 129.1, 128.8, 
128.7, 128.6, 127.4, 127.3, 127.2, 126.0, 47.5, 38.6, 34.2, 30.2, 12.3 ppm. Calcd (M+Na+) 
323.1776; Found 323.1776. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -13.2 º.  
 
(S)-4-(1-phenylpentan-3-yl)-1,1'-biphenyl (Table 4-1, (S)-23j). 
General procedure 5 was employed with ethyl 4-chlorobiphenyl (18.9 
mg, 0.1 mmol, 1.0 equiv), potassium 1-phenypentan-3-yl 
trifluoroborate potassium or (R)-4-1-phenypentan-3-yl trifluoroborate 
(38.0 mg, 0.15 mmol, 0.15 equiv, 98% ee), precatalyst (4.02 mg, 0.05 mmol, 5 mol %), and 
toluene/water (200 uL/ 100 uL). The reaction mixture was heated to 80 ºC for 24 h. A colorless 






was isolated following column chromatography (99:1 hexane/ether). A duplicate run of the 
enantioenriched variant on 0.05 mmol scale afforded the product with 75% ee. 1H NMR (300 
MHz, CD2Cl2): δ 7.67-7.61 (m, 2H), 7.61-7.55 (d, J=8.2 Hz, 2H), 7.45 (t, J=7.2 Hz, 2H), 7.38-
7.31 (m, 1H), 7.26 (t, J=8.0 Hz, 4H), 7.20-7.12 (m, 3H), 2.58-2.45 (m, 1H), 2.50 (t, J=7.8 Hz, 
2H), 2.09-1.85 (m, 2H), 1.85-1.57 (m, 2H), 0.82 (t, J=7.3 Hz, 3H) ppm. 13C NMR (75 MHz, 
CD2Cl2): δ 145.2, 143.2, 141.5, 139.1, 129.1, 128.8, 128.7, 128.6, 127.4, 127.3, 127.2, 126.0, 
47.5, 38.6, 34.2, 30.2, 12.3 ppm. Calcd (M+Na+) 323.1776; Found 323.1776. Optical rotation of 
this product [α]25D (c 1.00, CHCl3) = +10.8 º.  
 
5-((2R,4R)-4-(4-methoxyphenyl)pentan-2-yl)-3- 
methylbenzo[b]thiophene (Table 4-1, 24a). General 
procedure A2 was employed with 5-chloro-3-
methylbenzo[b]thiophene (18.2 mg, 0.1 mmol, 1.0 equiv), 
potassium (2R, 4R)-4-(4-methoxyphenyl)pentan-2-yl)-trifluoroborate (34.1 mg, 0.12 mmol, 1.2 
equiv), precatalyst (5.53 mg, 5.0 µmol, 5 mol %), ligand (3.68 mg, 5.0 µmol, 5 mol %), and 
toluene/water (200 uL/200 uL). The reaction mixture was heated up to 100 ºC for 24 h. A 
colorless oil (27.9 mg, 86% yield) was isolated following column chromatography (0.8-1% ether 
in hexane), which showed a 33:1 (anti/syn) determined by 1H NMR. 1H NMR (300 MHz, 
CDCl3): δ 7.78 (d, J= 8.3 Hz, 1H), 7.38 (d, J= 1.4 Hz, 1H), 7.15 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz, 
1H), 7.08-7.00 (m, 3H), 6.89-6.81 (m, 2H), 3.82 (s, 3H), 2.64 (sextet, J = 7.3 Hz, 1H), 2.50-2.36 
(m, 1H), 2.43 (d, J = 1.1 Hz, 3H), 1.92 (t, J= 7.5 Hz, 2H), 1.24 (d, J= 7.0 Hz, 3H), 1.14 (d, J= 6.9 
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 158.0, 143.4, 140.0, 139.6, 138.1, 132.2, 128.3, 






347.1446; Found 347.1444. Optical rotation of this product [α]25D  (c 1.00, CHCl3) = -137.3 º.  
 
5-((2S,4R)-4-(4-methoxyphenyl)pentan-2-yl)-3- 
methylbenzo[b]thiophene (Table 4-1, 24b). General 
procedure B was employed with 5-chloro-3-
methylbenzo[b]thiophene (18.2 mg, 0.1 mmol, 1.0 equiv), 
potassium (2R, 4R)-4-(4-methoxyphenyl)pentan-2-yl)-trifluoroborate (34.1 mg, 0.12 mmol, 1.2 
equiv), precatalyst (8.0 mg, 0.01 mmol, 10 mol %) and benzene/water (200 uL/200 uL). Schlenk 
tube was used in this reaction, which was heated up to 80 ºC for 48 h. A colorless oil (21.2 mg, 
65% yield) was isolated following column chromatography (0.8-1% ether in hexane), which 
showed a 5:1 (syn/anti) determined by 1H NMR. 1H NMR (300 MHz, CDCl3): δ 7.77 (d, J = 8.3 
Hz, 1H), 7.47 (d, J = 1.2 Hz, 1H), 7.18 (dd, J1 = 8.3 Hz, J2 = 1.4 Hz, 1H), 7.12-7.04 (m, 3H), 
6.89-6.81 (m, 2H), 3.80 (s, 3H), 2.80 (sextet, J = 7.1 Hz, 1H), 2.64 (sextet, J = 7.1 Hz, 1H), 2.43 
(s, 3H), 2.07-1.92 (m, 1H), 1.92-1.77 (m, 1H), 1.31 (d, J = 6.9 Hz, 3H), 1.24 (d, J = 6.8 Hz, 3H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 157.9, 143.9, 140.1, 140.0, 138.0, 132.2, 128.0, 123.8, 
122.8, 121.8, 120.0, 114.0, 55.4, 47.6, 37.8, 36.8, 22.9, 22.6, 14.2 ppm. HRMS: Calcd (M+Na+) 
347.1446; Found 347.1444. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +2.8 º.  
 
 ((1R, 2R)-2-methylcyclopentyl)benzene or ((1S, 2S)-2- 
methylcyclopentyl)benzene (Table 4-1, 25).[28] General procedure 4 was 
employed with chlorobenzene (30.4 µL, 0.3 mmol, 1.0 equiv) and potassium 
trans-2-methylcyclopent-1-yl trifluoroborate (85.5 mg, 0.45 mmol, 1.5 equiv). 







yield; run 2: 33.9 mg, 71% yield) was obtained by chromatography (100 % hexane). 1H NMR 
(300 MHz, CDCl3): δ 7.39-7.32 (m, 2H), 7.32-7.21 (m, 3H), 2.55-2.40 (m, 1H), 2.22-1.89 (m, 
3H), 1.89-1.72 (m, 3H), 1.47-1.28 (m, 1H), 0.99 (d, J = 6.3 Hz, 3H). 13C NMR (75 MHz, 




Racemic or (S)-3-(4-phenylbutan-2-yl)thiophene(Table 4-1, 26a). 
General procedure 5 was employed with 3-bromothiophene (28.1 uL, 
0.3 mmol, 1.0 equiv), potassium 4-phenylbut-2-yl trifluoroborate or 
potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 
96.3% ee), and toluene/water (600 uL/600 uL). The vessel was heated to 80 ºC for 24 h (48 h for 
reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 36.2 mg, 56% 
yield; run 2 (enantioenriched): 30.2 mg, 47% yield, 92% ee) was obtained by chromatography 
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the 
product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.34- 7.24 (m, 3H), 7.23-7.14 (m, 3H), 
7.03-6.99 (m, 1H), 6.99-6.96 (m, 1H), 2.90 (sextet, J = 7.0 Hz, 1H), 2.58 (t, J = 8.0 Hz, 2H), 
2.04-1.82 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 148.3, 142.6, 
128.5, 128.4, 126.8, 125.8, 125.4, 119.2, 39.9, 34.8, 33.8, 22.1 ppm. HRMS: Calcd (M+H+) 
217.1051; Found 217.1068. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +18.7 º.  
 
Racemic or (S)-3-(4-phenylbutan-2-yl)furan (Table 4-1, 26b). 






mmol, 1.0 equiv), potassium 4-phenylbut-2-yl trifluoroborate or potassium (R)-4-phenylbut-2-yl 
trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee), and toluene/water (600 uL/600 uL). The 
reaction mixture was heated to 100 ºC for 24 h (48 h for reaction with enantioenriched 
nucleophile). A colorless liquid (run 1 (racemic): 26.8 mg, 45% yield; run 2 (enantioenriched): 
24.6 mg, 41% yield, 90% ee) was isolated following column chromatography (100% hexane). A 
duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the product with 89% 
ee. 1H NMR (300 MHz, CDCl3): δ 7.42-7.39 (m, 1H), 7.35-7.25 (m, 3H), 7.25-7.16 (m, 3H), 
6.35 (t, J = 0.8 Hz, 1H), 2.71 (sextet, J = 7.0 Hz, 1H), 2.62 (t, J = 7.9 Hz, 1H), 1.96-1.77 (m, 
2H), 1.26 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.0, 142.6, 138.3, 130.7, 
128.5, 128.4, 125.8, 109.5, 39.4, 33.7, 29.8, 21.6 ppm. HRMS: Calcd (M+H+) 201.1279; Found 




7.3. GC yield and Enantio Excess Data in Chapter 3  
Calibration GC yield of experiment in Figure 3-2. 
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Cross-coupling reaction in each entry(time) are all set in 0.1 mmol. 




























































Enantio Excess of Product (Figure 3-7 to 3-11) 
Ligand 
Model I (Figure 3-7) Model I (Figure 3-8) 





P(o-tol)3, L1 66 1.18 89.6 2.15 1.63 2.00 
PhSPhos, L2 53 0.88 93.9 2.58 2.24 2.06 
SPhos, L3 23 0.35 83.1 1.77 2.03 1.47 
PPh3, L4 12 0.18 84.4 1.84 2.13 2.41 
PEt3, L5 9 0.13     
PMe3, L6 6 0.09     
neopPtBu2, L7 -69 -1.26 -47.4 -0.76 -0.03 removed 
PtBu3, L8 -81 -1.67 -62.8 -1.09 -1.35 -0.77 
PAd3, L9 -95 -2.72 -89.7 -2.16 -1.77 -1.73 
PhSPhos(4-CF3), L10 77 1.51 97.4 3.21 3.11 2.90 
PhSPhos(di-CF3), L11 92 2.36 97.8 3.33 3.66 3.48 
PhSPhos(otol), L12 36 0.56 83.1 1.77 1.94 1.84 
PhXPhos(4-CF3), L13 92 2.36 96.8 3.06 2.45 3.10 
PhXPhos(di-CF3), L14 92 2.36 97.6 3.26 3.43 3.75 
PhXPhos, L15 83 1.76 94.5 2.64 2.30 2.30 
3-C9, L1s 38 0.59 92.0 2.36 2.23 2.17 
tBu2PPh, L2s 21 0.32 67.3 1.21 0.81 removed 
RuPhos, L3s 16 0.24 82.9 1.76 2.00 1.48 
P(2-OMePh)3, L4s 16 0.24     
P(4-CF3-Ph)3, L5s 13 0.19     
P(p-tol)3, L6s 12 0.18     
XPhos, L7s 11 0.16 80.6 1.66 1.64 1.71 
monoXantPhos, L8s 11 0.16 85.3 1.88 2.42 2.40 
CyJohnPhos, L9s 10 0.15     
PBnPh2, L10s 10 0.15     
CPhos, L11s 9 0.13 82.3 1.73 1.64 1.56 
PnBu3, L12s 4 0.06     
nBuPAd2, L13s 4 0.12 51.0 0.84 0.46 0.26 
PCy3, L14s 4 0.06 66.4 1.19 1.54 1.06 
MePtBu2, L15s 3 0.04 58.9 1.00 0.74 removed 
tBu2PCy, L16s   45.4 0.73  removed 
tBuPCy2, L17s   61.0 1.05  0.46 
a Predicted ∆∆G(I) (24 ligands, Figure 3-11a); b Predicted ∆∆G (20 ligands, Figure 3-11c) 
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Conformer search 
A conformational search was performed for all phosphines using the OPLS3 force field and 
low-frequency-mode conformational search in Schrödinger MacroModel[28] with Python scripts 
partially based on work by Kristaps Ermanis and Jonathan Goodman.[29, 30] In order to represent 
the lowest-energy conformational space, conformers within 15 kcal/mol according to OPLS3 
were considered for further computations. To improve the representation of the parameter range, 
further conformers were added manually.  
DFT 
All DFT computations were performed using Gaussian16, Rev A.03[31] using the ultrafine 
integration grid and all other defaults unless stated otherwise. 
All structures were fully optimized at the PBE0/6-31+G(d) level (“Level 1”)[32-35] and 
frequency analysis was performed at the same level to confirm the presence of a ground state by 
the absence of imaginary frequencies.  
Two single point computations were performed on the optimized geometries:  
“Level 2”: PBE0/6-311G(2d,2p),[36] with NMR computations using the GIAO method.[37] 
“Level 3”: M06-2X/def2-TZVP,[38, 39] with NBO analysis using NBO 3.1[40] as implemented 
in Gaussian 
Level2//Level1 represents the recommended method combination by Latypov for the 
computation of phosphorus chemical shifts.[41] 
Parameters  
The steric descriptors require a point of reference opposite the substituents at phosphorus. In 
analogy to the definition of the Tolman Cone Angle,[42] this point was set to a distance of 2.28 Å 
from phosphorus, a representative Pd−P distance. The direction was determined by inverting and 
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scaling the sum of the three P−C vectors.  
%Vbur 
The buried volume was measured using a command line tool kindly 
provided by Luigi Cavallo that is equivalent to the web-based tool SambVca.[43-
45] As recommended, these parameters were used: Atomic radii: Bondi scaled by 





Verloop’s Sterimol parameters,[46] measured 
using a modified version of a Python script by 
Kelvin Jackson and Robert Paton[47, 48] using 
Bondi radii. The entire phosphine is treated as “substituent”, with the point of reference at a 
distance of 2.28 Å as described above.  
Solid Angle 
The software Solid-G by Ilia Guzei and Mark Wendt[49, 50] was used to measure the Solid 
Angle of the lowest-energy conformers only. 
EHOMO, ELUMO: Energies of the highest occupied and lowest virtual (Kohn-Sham) orbital 
(“HOMO” and “LUMO”) at Level 3. 
Vmin 
Minimum of the molecular electrostatic potential (MESP) in the 
phosphorus lone pair region.[51] Using the Gaussian cubegen utility, the 
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electrostatic potential was computed on a three-dimensional grid with the 
following parameters: based on the density at Level 3, centered 1.9 Å from 
P in the direction opposite the three substituents at P (“z”), determined as 
described above. Dimensions of the grid: 0.85 Å in two directions 
perpendicular to z, 0.5 Å along z. 25 points in each dimension. The lowest 
number on that grid was  
taken as Vmin. 
σ(31P): Isotropic shielding constant σ (proportional to the NMR chemical shift) of 
phosphorus at Level 2. 
NBO(P), ELP(P), Eσ*(P−C)min, Eσ*(P−C)avg 
Partial charge of phosphorus from the Natural 
population analysis at Level 3. Furthermore, the 
energies of the phosphorus lone pair orbital and 
the P−C antibonding orbitals σ*(P−C) as given by 
NBO. Both the lowest of the three, as well as the average  
of all three σ*(P−C) energies were considered as parameters in the 
modelling.  
Condensed parameters 
The distribution of properties across the conformers of a single phosphine was treated by 
using four condensed measures for each of the parameters described above: 
min: lowest value of a property of any conformer 
max: highest value of a property of any conformer 
Boltz: Boltzmann-weighted average of all conformers’ properties (T = 298.15 K) 
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minconf/MC: property value of the lowest-energy conformer 
For example, for conformers of PEt3, if all three chains point away from the P lone 
pair/metal coordination site (conformation adopted by Tolman in the determination of cone 
angles), steric properties such as B5 or the cone angle are minimal. In the most stable conformer, 
the three chains form a spiral around P (conformer used in the parameter illustrations above), 
with a higher value of B5. The Boltzmann-weighted average reflects these changes with an 
emphasis on the low-energy conformers. 
exceptions:  
Solid Angle: minconf only 
ELP(P), Eσ*(P−C)min, Eσ*(P−C)avg: Boltz and minconf only 
	
Multivariate Regression Modelling 
The experimentally measured selectivities were converted to free energy differences in 
transition states using the following expression, where x/y is either the enantiomeric ratio or the 
branched:linear ratio, R is the gas constant and T is the temperature of the reactions, 373.15 K: 
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Column: Chiral PAK IA 
Mobile Phase: A: H2O; B: Acetonitrile 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Me17b: syn/anti = 4.5:1
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